The PDF version
U.S. Department of Energy                                   ORDER
     Washington, D.C.                                    DOE 5400.5
                                                           2-8-90
                                                Change 2:  1-7-93

SUBJECT:  RADIATION PROTECTION OF THE PUBLIC AND THE ENVIRONMENT

1.  PURPOSE.  To establish standards and requirements for operations of the
    Department of Energy (DOE) and DOE contractors with respect to
    protection of members of the public and the environment against undue
    risk from radiation.

2.  SUPERSESSION.  DOE 5480.1A, ENVIRONMENTAL PROTECTION, SAFETY, AND HEALTH
    PROGRAM FOR DOE OPERATIONS, of 8-13-81, Chapter XI that addressed public
    and environmental radiation protection standards and control practices.

3.  SCOPE.  The provisions of this Order apply to all Departmental Elements
    and contractors performing work for the Department as provided by law
    and/or contract and as implemented by the appropriate contracting
    officer.

4.  IMPLEMENTING PROCEDURES AND REQUIREMENTS.  This Order becomes effective
    5-8-90.  Within 2 months from the date of issuance of the Order
    (2-8-90), the DOE Field Office Manager shall provide to the appropriate
    Program Office, with copy to EH-1 for review and comment:  a.  a
    certification for those areas covered by the Order for which field
    elements are in compliance; and/or b.  a request for exemption for areas
    not yet in compliance that includes a Plan for achieving compliance.
    Within 3 months of issuance, the appropriate Program Office will submit
    to EH-1 the certification and/or the request for exemption(s).  The
    compliance plan accompanying the request for exemption shall include
    schedules for activities which will lead to compliance with the
    requirements of this Order.

5.  POLICY.  It is the policy of DOE to implement legally applicable
    radiation protection standards and to consider and adopt, as
    appropriate, recommendations by authoritative organizations, e.g., the
    National Council on Radiation Protection and Measurements (NCRP) and
    the International Commission on Radiological Protection (ICRP).  It is
    also the policy of DOE to adopt and implement standards generally
    consistent with those of the Nuclear Regulatory Commission (NRC) for
    DOE facilities and activities not subject to licensing authority.

6.  OBJECTIVES.

    a.  Protecting the Public.  It is DOE's objective to operate its
        facilities and conduct its activities so that radiation exposures
        to members of the public are maintained within the limits
        established in this Order and to control radioactive contamination
        through the management of real and personal property.  It is also
        a DOE objective that potential exposures to members of the public
        be as far below the limits as is reasonably achievable (ALARA) and
        that DOE facilities have the capabilities, consistent with the types
        of operations conducted, to monitor routine and non-routine releases
        and to assess doses to members of the public.

    b.  Protecting the Environment.  In addition to providing protection to
        members of the public, it is DOE's objective to protect the
        environment from radioactive contamination to the extent practical.

7.  LEGISLATIVE AUTHORITY.  The Atomic Energy Act of 1954, as amended,
    authorizes the Department to protect the health and safety of the public
    against radiation in conducting the Department's programs.

8.  REFERENCES.

    a.  DOE 1324.2A, RECORDS DISPOSITION, of 9-13-88, which prescribes
        policies, procedures, standards, and guidelines for the orderly
        disposition of records of the DOE and its operating contractors.

    b.  DOE 5000.3B, OCCURRENCE REPORTING AND PROCESSING OF OPERATIONS
        INFORMATION, of 1-19-93, which establishes a system for reporting
        operations information related to DOE-owned or operated facilities
        and processing of the information.

    c.  DOE 5400.1, GENERAL ENVIRONMENTAL PROTECTION PROGRAM REQUIREMENTS,
        of 11-9-88, which establishes general environmental protection
        requirements.

    d.  DOE 5400.2A ENVIRONMENT COMPLIANCE ISSUE COORDINATION, of 1-31-89,
        which establishes requirements for coordination of significant
        environmental compliance issues.

    e.  DOE 5400.4, COMPREHENSIVE ENVIRONMENTAL RESPONSE, COMPENSATION, AND
        LIABILITY ACT PROGRAM, of 10-6-89, which establishes requirements
        for hazardous waste cleanup and notification.

    f.  DOE 5440.1E, NATIONAL ENVIRONMENTAL POLICY ACT COMPLIANCE PROGRAM,
        of 11-10-92, which establishes DOE policy for implementation of the
        National Environmental Policy Act of 1969.

    g.  DOE 5480.1B, ENVIRONMENT, SAFETY, AND HEALTH PROGRAM FOR DEPARTMENT
        OF ENERGY OPERATIONS, of 9-23-86, which outlines environmental,
        safety, and health protection policies and responsibilities.

    h.  DOE 5480.4, ENVIRONMENTAL PROTECTION, SAFETY, AND HEALTH PROTECTION
        STANDARDS, of 5-15-84, which identifies mandatory and reference
        environmental, safety, and health standards.

    i.  DOE 5480.5, SAFETY OF NUCLEAR FACILITIES, of 9-23-86, which
        establishes nuclear facility safety program requirements.

    j.  DOE 5480.6, SAFETY OF DEPARTMENT OF ENERGY-OWNED NUCLEAR REACTORS,
        of 9-23-86, which establishes nuclear reactor safety program
        requirements.

    k.  DOE 5480.11, RADIATION PROTECTION FOR OCCUPATIONAL WORKERS, of
        12-21-88, which establishes radiation protection standards and
        program requirements for workers.

    l.  DOE 5480.23, NUCLEAR SAFETY ANALYSIS REPORTS, of 4-10-92, which
        establishes requirements for contractors to develop safety analyses
        that establish and evaluate the adequacy of the safety bases of
        nuclear facilities.

    m.  DOE 5482.1B, ENVIRONMENT, SAFETY, AND HEALTH APPRAISAL PROGRAM, of
        9-23-86, which establishes the DOE environment, safety, and health
        appraisal program.

    n.  DOE 5483.1A, OCCUPATIONAL SAFETY AND HEALTH PROGRAM FOR DOE
        EMPLOYEES AT GOVERNMENT-OWNED, CONTRACTOR-OPERATED FACILITIES, of
        6-22-83, which establishes requirements for the protection of the
        health and safety of employees at DOE contractor-operated
        facilities.

    o.  DOE 5484.1, ENVIRONMENTAL PROTECTION, SAFETY, AND HEALTH PROTECTION
        INFORMATION REPORTING REQUIREMENTS, of 2-24-81, which establishes
        procedures for the reporting of information having environmental
        protection, safety, or health protection significance.

    p.  DOE Orders in the 5500 series that outline responsibilities for
        emergency preparedness and response.

    q.  DOE 5820.2A, RADIOACTIVE WASTE MANAGEMENT, of 9-26-88, which
        establishes policies and guidelines for the management of
        radioactive waste and contaminated facilities.

    r.  DOE 6430.1A, GENERAL DESIGN CRITERIA, of 4-6-89, which provides
        general design criteria for use in the acquisition of the
        Department's facilities and establishes responsibilities and
        authorities for the development and maintenance of those criteria.

    s.  DOE publication DOE/EH-0070, "External Dose-Rate Conversion Factors
        for Calculation of Dose to the Public," of 7-88, which provides
        conversion factors for use in calculating dose from radionuclides
        external to the body.

    t.  DOE publication DOE/EH-0071, "Internal Dose Conversion Factors for
        Calculation of Dose to the Public," of 7-88, which provides
        conversion factors for use in calculating dose from radionuclides
        in the body.

    u.  DOE Publication DOE/EH-0173T, "Environmental Regulatory Guide for
        Radiological Effluent Monitoring and Environmental Surveillance," of
        1-91, which establishes elements of a radiological monitoring
        program in support of DOE 5400.1 and 5400.5.

    v.  DOE publication DOE/EV/1830-T5, "A Guide to Reducing Radiation
        Exposure to as Low as Reasonably Achievable," of 4-80, which
        provides contractor personnel with general guidance regarding
        programs and techniques to reduce radiation exposure to levels as
        low as is reasonably achievable.

    w.  DOE publication, "Formerly Utilized Sites Remedial Action Program;
        Summary Protocol:  Identification - Characterization - Designation
        - Remedial Action - Certification," of 1-86, which provides
        procedures for conducting remedial actions at formerly utilized
        sites.

    x.  DOE/CH-8901, "A Manual for Implementing Residual Radioactive
        Material Guidelines; A Supplement to U.S. Department of Energy
        Guidelines for Residual Radioactive Material at Formerly Utilized
        Sites Remedial Action Program and Remote Surplus Facilities
        Management Program Sites," of 6-89, which provides guidance on the
        implementation of DOE residual radioactive material limits.

    y.  EPA Publication EPA-520/1-88-020, Federal Guidance Report No. 11,
        Limiting Values of Radionuclide Intake and Air Concentration and
        Dose Conversion Factors for Inhalation, Submersion, and Ingestion,"
        of 1988, which provides preferred dose conversion factors for use by
        Federal agencies.

    z.  Title 10 CFR Part 60, "Disposal of High-Level Wastes in Geologic
        Repositories," which prescribes rules governing the licensing of DOE
        to receive and possess source, special nuclear, and byproduct
        material at a geologic repository operations area.

    aa. Title 10 CFR Part 72, "Licensing Requirements for the Storage of
        Spent Fuel in an Independent Spent Fuel Storage Installation
        (ISFSI)," which establishes requirements, procedures, and criteria
        for licensing ISFSI.

    bb. Title 40 CFR Part 61, Subpart H, "National Emission Standard for
        Radionuclide Emissions from Department of Energy (DOE) Facilities,"
        which regulates radionuclide air emissions from DOE facilities.

    cc. Title 40 CFR Part 141, "National Interim Primary Drinking Water
        Regulations (Safe Drinking Water Act)," which prescribes
        radionuclide concentration limits for public drinking water.

    dd. Title 40 CFR Part 190, "Environmental Radiation Protection Standards
        for Nuclear Power Operations," which contains the radiation dose
        limits for members of the public in the general environment and
        curie release limits for radioactive materials released into the
        general environment from operations within the nuclear fuel cycle
        operations that are associated with the production of electrical
        power.

    ee. Title 40 CFR Part 191, "Environmental Standards for the Management
        and Disposal of Spent Nuclear Fuel, High-Level and Transuranic
        Wastes," which establishes requirements for the management and
        disposal of spent nuclear fuel, high-level, and transuranic wastes.

    ff. Title 40 CFR Part 192, "Standards for Remedial Actions at Inactive
        Uranium Processing Sites," of 1-5-83, which concerns the control
        of residual radioactive material at designated processing or
        disposal sites.

    gg. Title 42 U.S.C. 300, et seq., Safe Drinking Water Act, as amended,
        which authorizes EPA to promulgate regulations under two specific
        programs:  the first protects the Nation's public drinking water
        supplies; the second protects subsurface waters by regulating
        underground injection of materials.

    hh. Title 42 U.S.C. 2011, et seq., Atomic Energy Act of 1954, as
        amended, which authorizes the conduct of atomic energy activities
        and establishes authority for protecting the health and safety of
        the public.

    ii. Title 42 U.S.C. 4341, et seq., National Environmental Policy Act
        of 1969, as amended, which establishes broad national environmental
        policy.

    jj. Title 42 U.S.C. 7401, et seq., Clean Air Act, as amended, which
        provides requirements to protect and enhance the quality of the
        Nation's air resources, to promote the public health and welfare.

    kk. Title 47 Federal Register (FR) 47073, "Food and Drug Administration
        (FDA) Accidental Radioactive Contamination of Human Food and Animal
        Feeds; Recommendations for State and Local Agencies," which provides
        guidance for protecting consumers of produce following a nuclear
        accident.

    ll. Title 48 CFR Part 923.70, "Environmental Conservation and
        Occupational Safety," which contains the basic provisions of the
        DOE Environment, Conservation and Occupational Safety Program.

    mm. Title 48 CFR Part 970.23, "DOE Management and Operations Contracts,
        Environmental Conservation, and Occupational Safety," which contains
        supplemental information to Title 48 CFR Part 923.70 in providing
        the basic provisions of the DOE Environment, Conservation and
        Occupational Safety Program.

    nn. International Commission on Radiological Protection (ICRP)
        Publication 23, "Reference Man: Anatomical, Physiological and
        Metabolic Characteristics," Pergamon Press, Oxford, England.

    oo. ICRP Publication 26, "Recommendations of the International
        Commission on Radiological Protection," Pergamon Press, Oxford,
        England (1977).

    pp. ICRP Publication 30, "Limits for Intakes of Radionuclides by
        Workers."

    qq. ICRP Publication 45, "Quantitative Bases for Developing a Unified
        Index of Harm," Pergamon Press, Oxford, England.

    rr. ICRP Publication 48, "The Metabolism of Plutonium and Related
        Elements," Pergamon Press, Oxford, England.

    ss. National Council on Radiation Protection and Measurements (NCRP)
        Report No. 91, "Recommendations on Limits for Exposure to Ionizing
        Radiation," NCRP, Bethesda, MD 20814.

    tt. Nuclear Regulatory Commission, Regulatory Guide 1.86, "Termination
        of Operating Licenses for Nuclear Reactors," of 6-74, which
        establishes limits for surface contamination on materials and
        equipment.

    uu. Nuclear Regulatory Commission publication, "Guidelines for
        Decontamination of Facilities and Equipment Prior to Release for
        Unrestricted Use or Termination of Licenses for Byproduct, Source
        or Special Nuclear Material," of 7-82.

    vv. Oak Ridge National Laboratory (ORNL), Publication CCC - 475, 11-86,
        "CAAC - Code System for Implementation of Atmospheric Dispersion
        Assessment Required by the Clean Air Act."  RSIC Computer Code
        Collection.

9.  RESPONSIBILITIES AND AUTHORITIES.

    a.  The Secretary.  Many provisions in this Order permit and/or
        necessitate the exercise of discretion and/or judgment in carrying
        out the requirements of the Order.  In those instances, the
        determination of whether, in the exercise of such discretion
        and/or judgment, the requirements of this Order were complied with
        rests initially with the relevant Department authority and,
        ultimately, with the Secretary.  The Secretary retains the sole
        and final authority to determine what acts are necessary to comply
        with this Order.  Further, the Secretary retains the authority to
        suspend any and all requirements under this Order whenever the
        Secretary deems it necessary.  This authority may be delegated by
        the Secretary as appropriate.

    b.  In addition to those responsibilities and authorities contained in
        DOE 5480.1B and DOE 5400.1, the following responsibilities and
        authorities are assigned:

        (1)  Assistant Secretary for Environment, Safety and Health (EH-1)

             (a)  Develop DOE public and environmental radiation protection
                  policy and requirements; and

             (b)  Approve, if warranted, specific exceptions to this Order,
                  pursuant to provisions in DOE 5400.1 and DOE 5820.2A.

        (2)  Program Secretarial Officers.

             (a)  Implement DOE public and environmental radiation
                  protection policy and requirements in their respective
                  programs; and

             (b)  Implement, if warranted, interim control strategies
                  proposed by field organizations pursuant to this Order and
                  DOE 5820.2A.

        (3)  Heads of Field Elements.

             (a)  Implement provisions of this Order for their respective
                  activities;

             (b)  Maintain appropriate capabilities at each operating site
                  for monitoring and assessing routine and unplanned
                  releases of radioactive materials, with respect to the
                  characteristics of radioactive material released and the
                  release modes, consistent with the types of operations
                  conducted;

             (c)  Process specific requests for exceptions to this Order,
                  pursuant to paragraph II.1a(4); and

             (d)  Temporarily suspend the requirements of this Order when
                  doing so is in their judgement necessary to minimize
                  damage to life or property or to protect public health
                  or safety.  Whenever this provision is invoked, such
                  suspension and the reason therefore are to be reported
                  to EH-1 at the earliest practicable time.

        (4)  Director, Naval Nuclear Propulsion Program:  Executive Order
             12344, statutorily prescribed by PL 98-525 (42 USC 7158 note)
             establishes the responsibilities and authority of the Director,
             Naval Nuclear Propulsion Program (who is also the Deputy
             Assistant Secretary for Naval Reactors within the Department)
             over all facilities and activities which comprise the Program,
             a joint Navy-DOE organization.  The policy principle promoted
             by these executive and legislative actions is cited in the
             Executive Order as "...preserving the basic structure,
             policies, and practices developed for this Program in the
             past...".  Accordingly, The Naval Nuclear Propulsion Program is
             exempt from the provisions of this Order.  The Director shall
             maintain an environmental protection program to ensure
             compliance with applicable environmental statues and
             regulations.  The Director and EH-1 shall cooperatively develop
             information exchange and other mutually beneficial programs as
             appropriate, consistent with PL 98-525.

10. DEFINITIONS.

    a.  As Low As Reasonably Achievable (ALARA) is a phrase (acronym) used
        to describe an approach to radiation protection to control or
        manage exposures (both individual and collective to the work force
        and the general public) and releases of radioactive material to
        the environment as low as social, technical, economic, practical,
        and public policy considerations permit.  As used in this Order,
        ALARA is not a dose limit, but rather it is a process that has as
        its objective the attainment of dose levels as far below the
        applicable limits of the Order as practicable.

    b.  Best Available Technology (BAT) means the preferred technology for
        treating a particular process liquid waste, selected from among
        others after taking into account factors related to technology,
        economics, public policy, and other parameters.  As used in this
        Order, BAT is not a specific level of treatment, but the
        conclusion of a selection process that includes several treatment
        alternatives.

    c.  Derived Concentration Guide (DCG) is the concentration of a
        radionuclide in air or water that, under conditions of continuous
        exposure for one year by one exposure mode (i.e., ingestion of
        water, submersion in air, or inhalation), would result in an
        effective dose equivalent of 100 mrem 0.1 rem (1 mSv).  DCGs do
        not consider decay products when the parent radionuclide is the
        cause of the exposure (DCG values are presented in Chapter III)
        (1 rem = 0.01 sievert).

    d.  Dose Terms.

        (1)  Absorbed Dose is the energy imparted to matter by ionizing
             radiation per unit mass of irradiated material at the place
             of interest in that material.  The absorbed dose is expressed
             in units of rad (or gray).  (1 rad = 0.01 gray.)

        (2)  Collective Dose Equivalent and Collective Effective Dose
             Equivalent are the sums of the dose equivalents or effective
             dose equivalents of all individuals in an exposed population
             within an 80-km radius, for the purposes of this Order, and
             they are expressed in units of person-rem, (or person-sievert).
             When the collective dose equivalent of interest is for a
             specific organ, the units would be organ-rem (or
             organ-sievert).  For purposes of this Order, the 80-km distance
             shall be measured from a point located centrally with respect
             to major facilities or DOE program activities.

        (3)  Committed Dose Equivalent is the predicted total dose
             equivalent to a tissue or organ over a 50-year period after a
             known intake of a radionuclide into the body.  It does not
             include contributions from external dose.  Committed dose
             equivalent is expressed in units of rem (or sievert).

        (4)  Committed Effective Dose Equivalent is the sum of the committed
             dose equivalents to various tissues in the body, each
             multiplied by the appropriate weighting factor.  Committed
             effective dose equivalent is expressed in units of rem (or
             sievert).

        (5)  Deep Dose Equivalent, as used in this Order, means the dose
             equivalent in tissue at a depth of 1 cm deriving from external
             (penetrating) radiation.

        (6)  Dose Equivalent is the product of absorbed dose in rad (or
             gray) in tissue and a quality factor.  Dose equivalent is
             expressed in units of rem (or sievert).

        (7)  Effective Dose Equivalent is the summation of the products of
             the dose equivalent received by specified tissues of the body
             and a tissue-specific weighting factor.  This sum is a
             risk-equivalent value and can be used to estimate the
             health-effects risk of the exposed individual.  The
             tissue-specific weighting factor represents the fraction of
             the total health risk resulting from uniform whole-body
             irradiation that would be contributed by that particular
             tissue.  The effective dose equivalent includes the committed
             effective dose equivalent from internal deposition of
             radionuclides and the effective dose equivalent due to
             penetrating radiation from sources external to the body.
             Effective dose equivalent is expressed in units of rem (or
             sievert).

        (8)  Public Dose means the dose received by member(s) of the public
             from exposure to radiation and to radioactive material released
             by a DOE facility or operation, whether the exposure is within
             a DOE site boundary or off-site.  It does not include dose
             received from occupational exposures, doses received from
             naturally occurring "background" radiation, doses received as a
             patient from medical practices, or doses received from consumer
             products.

        (9)  Weighting Factor is tissue-specific and represents the fraction
             of the total health risk resulting from uniform, whole-body
             irradiation that could be contributed to that particular
             tissue.  The weighting factors recommended by the ICRP
             (Publication 26) and used here are

           --------------------------------------------------
           | Organ or Tissue               Weighting Factor |
           | ---------------               ---------------- |
           | Gonads                             0.25        |
           | Breasts                            0.15        |
           | Red Bone Marrow                    0.12        |
           | Lungs                              0.12        |
           | Thyroid                            0.03        |
           | Bone Surfaces                      0.03        |
           | Remainder 1/                       0.30        |
           |________________________________________________|

            1/  "Remainder means the five other organs with the highest
                dose (e.g., liver, kidney, spleen, thymus, adrenal,
                pancreas, stomach, small intestine, or upper and lower
                large intestine, but excluding skin, lens of the eye,
                and extremities).  The weighting factor for each of
                these organs is 0.06.

        (10) Quality Factor is the principal modifying factor used to
             regulate the dose equivalent from the absorbed dose.  For the
             purposes of this Order, the following quality factors, which
             are taken from DOE 5480.11, are to be used.

           __________________________________________________________
           | Radiation Type                          Quality Factor |
           | --------------                          -------------- |
           | X-rays, gamma rays,                           1        |
           | positrons, and electrons                               |
           |   (including tritium)                                  |
           | - - - - - - - - - - - - - - - - - - - - - - - - - - -  |
           | Neutrons, <10 keV                             3        |
           | - - - - - - - - - - - - - - - - - - - - - - - - - - -  |
           | Neutrons, >10 keV                            10        |
           | Protons and single charged                             |
           |   particles of unknown energy with                     |
           |   rest mass > one atomic mass unit                     |
           | - - - - - - - - - - - - - - - - - - - - - - - - - - -  |
           | Alpha particles                              20        |
           | Multiple-charged particles                             |
           |   (and particles of unknown                            |
           |   charge) of unknown energy                            |
           |________________________________________________________|

             For neutrons of known energies, the more detailed quality
             factors given in DOE 5480.11 may be used.

    e.  Members of the Public means persons who are not occupationally
        associated with the DOE facility or operations, i.e., persons
        whose assigned occupational duties do not require them to enter
        the DOE site.  (Also see Dose Terms:  Public Dose.)

    f.  Monitoring Terms.

        (1)  Effluent Monitoring is the collection and analysis of samples
             or measurements of liquid and gaseous effluents for purposes
             of characterizing and quantifying contaminants, assessing
             radiation exposures of members of the public, and demonstrating
             compliance with applicable standards.

        (2)  Environmental Surveillance is the collection and analysis of
             samples of air, water, soil, foodstuffs, biota, and other
             media from DOE sites and their environs and the measurement
             of external radiation for purposes of demonstrating compliance
             with applicable standards, assessing radiation exposures of
             members of the public, and assessing effects, if any, on the
             local environment.

    g.  Protective Action Guides (PAG) are projected numerical dose values
        established by EPA, DOE, or States for individuals in the
        population.  These values may trigger protective actions that would
        reduce or avoid the projected dose.

    h.  Radioactivity means the property or characteristic of radioactive
        material to spontaneously "disintegrate" with the emission of
        energy in the form of radiation.  The unit of radioactivity is the
        curie (or becquerel).

    i.  Reference Man means a hypothetical aggregation of human (male and
        female) physical and physiological characteristics arrived at by
        international consensus (ICRP Publication 23).  These
        characteristics may be used by researchers and public health
        workers to standardize results of experiments and to relate
        biological insult from ionizing radiation to a common base.  The
        "reference man" is assumed to inhale 8400 cubic meters of air in a
        year and to ingest 730 liters of water in a year.

    j.  Release of Property, as used in this Order, means the exercising
        of DOE's authority to release property from its control after
        confirming that residual radioactive material (over which DOE has
        authority) on the property has been determined to meet the
        guidelines for residual radioactive material in Chapter IV or any
        other applicable radiological requirements.  There may be
        instances in which DOE or other authority will impose restrictions
        on the management and/or use of the property if the residual
        radioactive material guidelines of Chapter IV are not met or if
        other applicable Federal, State, or local requirements cause the
        imposition of such restrictions.

    k.  Remedial Action means those actions consistent with permanent remedy
        taken instead of, or in addition to, removal action in the event of
        a release or threatened release of a hazardous substance into the
        environment, to prevent or minimize the release of hazardous
        substances so that they do not migrate to cause substantial danger
        to present or future public health or welfare or the environment.

    l.  Residual Radioactive Material means any radioactive material which
        is in or on soil, air, equipment, or structures as a consequence
        of past operations or activities.

    m.  Settleable Solids means those solids suspended in waste water that
        are determined to be settleable using Method 209 E, Settleable
        Solids pp 98 and 99, 16th edition, Standard Methods for Examination
        of Water and Waste Water.

    n.  Sewerage Terms.

        (1)  Sewage means the waste matter that passes through sewers.

        (2)  Sewer means the artificial conduit, usually underground, for
             carrying off waste water and refuse.

        (3)  Sewerage means the system of sewers.

    o.  Soil Column is an in situ volume of soil down through which liquid
        wastes percolate from ponds, cribs, seepage basins, or trenches.

    p.  Stochastic Effects are biological effects, the probability, rather
        than the severity, of which is a function of the magnitude of the
        radiation dose without threshold; i.e., stochastic effects are
        random in nature.  Nonstochastic Effects are biological effects,
        the severity of which, in affected individuals, varies with the
        magnitude of the dose above a threshold value.

BY ORDER OF THE SECRETARY OF ENERGY:



                                        DONNA R. FITZPATRICK
                                        Assistant Secretary
                                        Management and Administration



                             TABLE OF CONTENTS

CHAPTER I - GENERAL

1.   Background                                                    I-1
2.   Dose Standards and Terminology                                I-1
     a.   International Commission on Radiological
          Protection                                               I-1
     b.   Other Sources of Regulations and Guidance                I-1
3.   Dose Limit Selection                                          I-2
4.   As Low As Reasonably Achievable                               I-2
5.   Liquid Wastes and Effluents                                   I-2
     a.   Protection of Resources                                  I-2
     b.   Treatment of Liquid Radioactive Waste Streams            I-2
6.   Environmental Protection                                      I-2
7.   Discharges to Sanitary Sewerage                               I-3
8.   Effluent Monitoring and Environmental Surveillance            I-3
     a.   Demonstration of Compliance                              I-3
     b.   Monitoring and Surveillance Requirements                 I-3
9.   Residual Radioactive Material                                 I-3
10.  Dose Evaluations                                              I-3
     a.   Standard Methods                                         I-3
     b.   Supplemental Documents                                   I-4
     c.   EPA Models                                               I-4
11.  Reporting                                                     I-4

CHAPTER II - REQUIREMENTS FOR RADIATION PROTECTION OF THE PUBLIC
             AND THE ENVIRONMENT

1.   Public Dose Limits                                            II-1
     a.   DOE Public Dose Limit--All Exposure Modes,
          All DOE Sources of Radiation                             II-1
     b.   Airborne Emissions Only,--All DOE Sources of
          Radionuclides                                            II-3
     c.   All Exposure Modes, Sources from Management,
          and Storage of Spent Nuclear Fuel, High-Level,
          and Transuranic Wastes at Disposal Facilities            II-4
     d.   Drinking Water Pathway Only, All DOE Sources of
          Radionuclides                                            II-5
2.   The ALARA Process                                             II-5
     a.   Considerations                                           II-5
     b.   Evaluations                                              II-6
3.   Management and Control of Radioactive Materials in
     Liquid Discharges and Phaseout of Soil Columns                II-6
     a.   Discharges of Liquid Waste to Surface Waters             II-6
     b.   Discharges of Liquid Waste to Aquifers
          and Phaseout of Soil Columns                             II-8
     c.   Management of Soil Columns, Natural Draining
          Systems, and Ground Water at Inactive Sites Previously
          Contaminated with Radioactive Material                   II-9
     d.   Discharges of Liquid Waste to Sanitary Sewerage          II-9
     e.   Exceptions for Liquid Waste Control Requirements         II-10
4.   Management of Low-Level Radioactive Solid Waste               II-10
5.   Release of Property Having Residual Radioactive Material      II-10
     a.   Release of Real Property                                 II-10
     b.   Release of Personal Property                             II-10
     c.   Release of Materials and Equipment                       II-11
6.   Demonstration of Compliance with the Dose Limits              II-12
     a.   Monitoring and Surveillance                              II-12
     b.   Dose Evaluations                                         II-12
7.   Reporting Requirements                                        II-14
8.   Records                                                       II-15
     a.   Content                                                  II-15
     b.   Retention                                                II-15
9.   Units                                                         II-15

CHAPTER III - DERIVED CONCENTRATION GUIDES FOR AIR AND WATER

1.   Purpose                                                       III-1
2.   Basis                                                         III-1
     a.   Exposure Conditions for Ingestion of Water and
          Inhalation                                               III-1
     b.   Exposure Conditions for Air Immersion                    III-2
     c.   Application to Mixtures of Radionuclides                 III-3
3.   Limitations                                                   III-3
Figure III-1 - Derived Concentration Guides for
               Members of the Public from Ingested Water and
               Inhalation Resulting in 100 mrem/yr                 III-4
Figure III-2 - Alternative Absorption Factors and Lung
               Retention Classes for Specific Compounds            III-27
Figure III-3 - Derived Concentration Guides for Members
               of the Public from External Exposure During
               Immersion in a Contaminated Atmospheric Cloud       III-36

CHAPTER IV - RESIDUAL RADIOACTIVE MATERIAL

1.   Purpose                                                       IV-1
2.   Implementation                                                IV-1
     a.   Residual Radioactive Material                            IV-1
     b.   Basic Dose Limit                                         IV-2
     c.   Guideline                                                IV-2
     d.   Authorized Limit                                         IV-2
     e.   ALARA Applications                                       IV-3
3.   Basic Dose Limits                                             IV-3
     a.   Defining and Determining Dose Limits                     IV-3
     b.   Unusual Circumstances                                    IV-3
4.   Guidelines for Residual Radioactive Material                  IV-3
     a.   Residual Radionuclides in Soil                           IV-3
     b.   Airborne Radon Decay Products                            IV-4
     c.   External Gamma Radiation                                 IV-5
     d.   Surface Contamination                                    IV-5
     e.   Residual Radionuclides in Air and Water                  IV-5
5.   Authorized Limits for Residual Radioactive Material           IV-5
     a.   Establishment of Authorized Limits                       IV-5
Figure IV-1 - Surface Contamination Guidelines                     IV-6
     b.   Application of Authorized Limits                         IV-7
6.   Control of Residual Radioactive Material                      IV-7
     a.   Operational and Control Requirements                     IV-7
     b.   Interim Storage                                          IV-8
     c.   Interim Management                                       IV-8
     d.   Long-Term Management                                     IV-9
7.   Supplemental Limits and Exceptions                            IV-9
     a.   Supplemental Limits                                      IV-10
     b.   Exceptions                                               IV-10
     c.   Justification for Supplemental Limits and Exceptions     IV-10
8.   Sources                                                       IV-11
     a.   Basic Dose Limits                                        IV-11
     b.   Generic Guidelines for Residual Radioactive Material     IV-11
     c.   Control of Radioactive Wastes and Residues               IV-12


                                 CHAPTER I

                                  GENERAL

1.  BACKGROUND.  This Order has been developed to integrate, consolidate,
    and update the portions of DOE 5480.1B that addressed public and
    environmental radiation protection standards and control practices.
    Specifically, this Order replaces requirements of DOE 5480.1B, Chapter
    XI; adopts current guidance and standards issued by national and
    international authoritative bodies on radiation protection; incorporates
    current regulatory requirements applicable to DOE operations; and
    consolidates and upgrades DOE guidance for contaminated property.  The
    following paragraphs provide a summary of the topics considered in this
    Order.

2.  DOSE STANDARDS AND TERMINOLOGY.

    a.  International Commission on Radiological Protection (ICRP).  This
        Order adopts and implements radiation protection dose standards
        consistent with the recommendations of the ICRP.  In 1977, the
        ICRP recommended a system of dose limitations that has been
        adopted and implemented by essentially all countries with nuclear
        programs.  The ICRP system of dose limitations provides a
        scientific basis for health protection and selection of dose
        limits.  The system also reflects current information on health
        risks, dosimetry, and radiation practices, and promotes a more
        uniform and consistent application of radiation protection among
        diverse activities than had previously been possible.  The ICRP
        system is based on sophisticated analytical models and requires
        computer capabilities for making evaluations or using the dose
        conversion tables produced from such evaluations.

    b.  Other Sources of Regulations and Guidance.  DOE is required to
        comply with legally applicable rules and regulations of other
        Federal, State, and local agencies, some of which have not adopted
        the ICRP system.  The result is a mixture of dose standards,
        terminology, and units.  Therefore, some dose limits in this Order
        are expressed in terms of effective dose equivalent, consistent
        with current ICRP recommendations, while others are expressed in
        terms of dose equivalent to the whole body or to specific organs,
        consistent with pre-1977 recommendations of ICRP.  The presentation
        of this Order includes both the more traditional dose terms and
        units and the new dose terms and concepts introduced by the ICRP for
        their system of dose limitations.  Definitions presented in this
        Order are consistent with the definitions presented in related
        Orders, such as DOE 5480.11.

3.  DOSE LIMIT SELECTION.  The DOE primary standard of 100 mrem (1 mSv)
    effective dose equivalent to members of the public in a year is lower
    than the previous primary limit of 500 mrem (5 mSv).  The lower value
    was selected in recognition of the ICRP recommendation to limit the
    long-term average effective dose equivalent to 100 mrem (1 mSv) per
    year, or less.  Experience suggests that the lower dose is readily
    achievable for normal operations of DOE facilities.  A higher dose
    limit, not to exceed the 500-mrem effective dose equivalent recommended
    by ICRP as an occasional annual limit, may be authorized for a limited
    period if it is justified by unusual operating conditions.

4.  AS LOW AS REASONABLY ACHIEVABLE (ALARA).  The DOE primary public dose
    limit is based on consideration of the potential risk of
    radiation-induced fatal cancers and serious genetic defects (i.e., the
    ICRP risk-based system).  The ICRP recommends that doses to individuals
    be within the appropriate dose limit for the individuals and that all
    exposures be ALARA.  Accordingly, this Order adopts the ALARA process
    in planning and carrying out all DOE activities.

5.  LIQUID WASTES AND EFFLUENTS.

    a.  Protection of Resources.  In addition to limiting dose to members
        of the public (onsite or offsite) to the primary radiation
        protection standards established in this Order and to the applicable
        limits of EPA and State regulations, additional controls on the
        release of liquid wastes are adopted to reduce the potential for
        radiological contamination of natural resources such as land, ground
        and surface water, and ecosystems.

    b.  Treatment of Liquid Radioactive Waste Streams.  Standards for liquid
        effluent discharges are driven by the DOE ALARA policy and objective
        to minimize contamination in the environment to the extent
        practicable.  The Order adopts the "best available technology" (BAT)
        as the appropriate level of treatment for liquid wastes containing
        radioactive material and provides that the BAT be phased in at the
        earliest practicable time.  Technical and economic considerations
        are included in determining the BAT.  Based on cost and benefit
        considerations, radioactive waste streams that contain radionuclide
        concentrations of not more than the derived concentration guide
        (DCG) reference values at the point of discharge to a surface
        waterway normally will not require treatment to further reduce the
        concentration.  BAT treatment is provided to protect ground water
        and to prevent radionuclide buildup in soil.

6.  ENVIRONMENTAL PROTECTION.  The phasing out of the use of soil columns
    and the additional requirements associated with the burial of low-level
    radioactive wastes (discussed in Chapter II) address concerns with
    potential long-term contamination of the environment on and near DOE
    activities and sites.  These requirements are intended to prevent the
    buildup of contamination in soils and ground water and to protect the
    environment from the spread of contamination from burial trenches and
    pits.

7.  DISCHARGES TO SANITARY SEWERAGE.  The control of releases of liquid
    wastes to community sanitary sewer systems is designed to be generally
    consistent with requirements imposed by NRC on its licensees.  As
    discussed in Chapter II, the "best available technology" (BAT) selection
    process is to be applied to the treatment of liquid wastes released to
    sanitary sewerage when concentrations of radionuclides would otherwise
    exceed five times the DCG reference values given in Chapter III.
    Operators should ensure that the total annual discharge of radioactive
    material to the sanitary sewer system will not cause exposures to
    members of the general public that will result in doses exceeding a
    small fraction of the basic annual dose limit.

8.  EFFLUENT MONITORING AND ENVIRONMENTAL SURVEILLANCE.

    a.  Demonstration of Compliance.  Demonstrations of compliance with
        requirements of this Order generally will be based upon calculations
        that make use of information obtained from monitoring and
        surveillance programs.  The abilities to detect, quantify, and
        adequately respond to unplanned releases of radioactive material to
        the environment also rely on in-place effluent monitoring,
        monitoring of environmental transport and diffusion conditions, and
        assessment capabilities.  This will enable DOE to develop useful
        data and to collect and analyze pertinent information on unplanned
        releases in a timely manner.  It is the intent of DOE that the
        monitoring and surveillance programs for the DOE activities,
        facilities, and locations be of high quality.  Although some
        differences result from specific site or specific activity
        conditions, uniformity in the methods and performance criteria used
        in obtaining the information is desirable.

    b.  Monitoring and Surveillance Requirements.  To ensure that the
        effluent monitoring and environmental surveillance programs are of
        good quality at all DOE facilities and sites, certain requirements
        and recommendations are provided in DOE publication DOE/EH-073T
        which deal with radiological effluent monitoring and environmental
        surveillance.

9.  RESIDUAL RADIOACTIVE MATERIAL.  DOE practices and requirements for
    residual radioactive material are presented in Chapter IV, including
    limits of potential dose, authorized contamination limits for the
    release of property, and ALARA considerations.

10. DOSE EVALUATIONS

    a.  Standard Methods.  Data developed by the Department to demonstrate
        that DOE operations comply with applicable standards and
        requirements should be correct and representative.  Accordingly,
        this Order requires that calculations of dose to the public from
        exposures resulting from both routine and unplanned activities be
        performed using standard EPA or DOE dose conversion factors or
        analytical models prescribed in regulations applicable to DOE
        operations.

    b.  Supplemental Documents.  The dose conversion factors and derived
        concentrations needed to make dose evaluations to meet DOE
        requirements are provided in Chapter III and three supplemental
        documents:  EPA-520/1-88-020, Federal Guidance Report No. 11,
        "Limiting Values of Radionuclide Intake and Air Concentration
        Factors for Inhalation, Submersion, and Ingestion;" DOE/EH-0071,
        "Internal Dose Conversion Factors for Calculation of Dose to the
        Public," and DOE/EH-0070, "External Dose-Rate Conversion Factors
        for Calculation of Dose to the Public."  The dose conversion
        factors in these documents provide the primary basis for determining
        compliance with this Order.  The table of DCGs (Chapter III) has
        been expanded considerably to present all classes of uptake and
        retention.

    c.  EPA Models.  The use of AIRDOS/RADRISK, CAP-88, or AIRDOS-PC models
        is prescribed by EPA in 40 CFR Part 61, Subpart H, to evaluate
        potential doses from airborne releases.  Thus, two evaluations of
        doses from airborne pathways could be required:  one to satisfy 40
        CFR Part 61 requirements and one for DOE purposes using contemporary
        dosimetry.  [Caution:  Unless modified, AIRDOS/RADRISK (also known
        as CAP-88 or AIRDOS-PC) is not suitable for calculating doses from
        accidents.]

11. REPORTING.  The Order addresses the notification of headquarters
    personnel when DOE activities might have caused, or might cause, a
    noncompliance with requirements of this Order.  These requirements are
    in addition to the general requirements for reporting, specified in DOE
    5484.1.  "Federally permitted" designation of releases, for purposes of
    EPA reporting requirements, are addressed in section II.7.



                               CHAPTER II

                   REQUIREMENTS FOR RADIATION PROTECTION
                     OF THE PUBLIC AND THE ENVIRONMENT

1.  PUBLIC DOSE LIMITS.  Dose limits for members of the public are presented
    in this chapter.  The primary public dose limits include consideration
    of all exposure modes from all DOE activities (including remedial
    actions).  The primary dose limit is expressed as an effective dose
    equivalent, a term developed by the ICRP for their risk-based system,
    which requires the weighted summation of doses to various organs of the
    body.  Additional public dose limits are established by EPA regulations
    for exposures to several selected sources or exposure modes (pathways or
    conditions).  Public dose limits promulgated by EPA for selected
    exposure modes are sometimes expressed as dose equivalents, which do not
    include risk-based weighting or summation of doses to various organs,
    and sometimes expressed as effective dose equivalent.  DOE must also
    comply with legally applicable requirements (e.g., 40 CFR Parts 61, 191,
    and 192 and 10 CFR Parts 60 and 72), including administrative and
    procedural requirements.  Except for those provided in paragraph
    II.1a(4), administrative and procedural requirements of legally
    applicable regulations are not addressed in this Order.  Such legally
    applicable regulations must be consulted for provisions not addressed in
    this Order.

    a.  DOE Public Dose Limit--All Exposure Modes, All DOE Sources of
        Radiation.  Except as provided by II.1a(4), the exposure of members
        of the public to radiation sources as a consequence of all routine
        DOE activities shall not cause, in a year, an effective dose
        equivalent greater than 100 mrem (1 mSv).  Dose evaluations should
        reflect realistic exposure conditions (see II.6b).

        (1)  Dose Components.  The limit of 100 mrem (1 mSv) effective dose
             equivalent in a year specified in paragraph II.1a is the sum of
             the effective dose equivalent (or deep dose equivalent, if
             dosimeter data are used) from exposures to radiation sources
             external to the body during the year plus the committed
             effective dose equivalent from radionuclides taken into the
             body during the year.

        (2)  Exposure Modes.  Other than for sources specifically excepted,
             doses to members of the public from all exposure modes that
             could contribute significantly to the total dose shall be
             considered for evaluation. Requirements and methods for
             performing the evaluations are discussed in paragraph II.6.

        (3)  Application.  The public dose limits in paragraph II.1a apply
             to doses from exposures to radiation sources from routine
             activities, including remedial actions and naturally occurring
             radionuclides released by DOE processes and operations.  The
             dose limits also apply to the doses to individuals who are
             exposed to radiation or contamination by radionuclides at
             properties subsequent to remedial action and release of the
             property.  Limits for radon and its decay products in air are
             provided in terms of Working Levels and concentrations in air
             and are addressed independently (Chapter IV and Figure III-1).
             In addition, DOE operators are required to report DOE-related
             effective dose equivalent contributions of 10 mrem (0.10 mSv)
             or more in a year (see paragraph II.7).

             (a)  Doses from Sources Other than DOE Man-Made or Enhanced
                  Natural Radionuclides.  Except for medical sources,
                  consumer products, residual fallout from past nuclear
                  accidents and weapons tests, and naturally occurring
                  radiation sources, DOE operators shall make a reasonable
                  effort to be aware of the existence of other than DOE
                  man-made sources of radiation which, combined with the
                  DOE sources, might present a potential for exceeding
                  contributions of 10 mrem (0.1 mSv) effective dose
                  equivalent in a year.  Reasonable efforts shall be made
                  to limit dose to members of the public, from multiple
                  sources of radiation, to 100-mrem (1 mSv) effective dose
                  equivalent, or less, in a year.  EH-1 and the appropriate
                  Headquarters Program Offices shall be notified if the
                  100-mrem in a year dose limit cannot be achieved.

             (b)  Doses Not Included in Evaluations.  The public dose limits
                  do not apply to doses from medical exposures, consumer
                  products, and generally do not apply to doses from
                  naturally occurring radiation sources or from exposures
                  due to accident conditions, where controls of exposures
                  cannot be maintained.  The policy and requirements
                  relating to protective actions following the uncontrolled
                  release of radionuclides are set forth in the DOE 5500
                  series of directives.  Requirements for planning to
                  prevent or mitigate accidents and their effects are
                  presented in DOE 5480.5 and DOE 5480.6.

             (c)  Doses from Underground Nuclear Weapons Tests.  The
                  unanticipated release of radioactive material due to
                  venting or seepage from underground nuclear weapons is
                  considered to be an accident.  However, the release of
                  radioactive material that results from planned sampling
                  or reentry following an underground nuclear weapons test
                  is not an accidental condition, and shall be controlled
                  in accordance with this standard.

        (4)  Exceptions.  Unusual circumstances could affect a DOE activity
             in such a manner that the potential public dose could exceed an
             effective dose equivalent of 100 mrem (1 mSv) in a year.

             (a)  Temporary Increases of Dose Limit.  If avoidance of the
                  higher exposures is impracticable, the Manager of the DOE
                  Field Office, in coordination with their Program Office,
                  may request, from EH-1, specific authorization for a
                  temporary public dose limit higher than 100 mrem (1
                  mSv), but not to exceed 500 mrem (5 mSv), for the year.
                  The temporary higher dose limit derives from ICRP
                  recommendations (ICRP Publication 45) for a principal
                  stochastic dose limit of 100 mrem (1 mSv) effective dose
                  equivalent in a year for exposures to the public, and a
                  subsidiary dose limit of 500 mrem (5 mSv) effective dose
                  equivalent in a year, for some years, if the dose averaged
                  over a lifetime does not exceed the principal limit of 100
                  mrem (1 mSv) effective dose equivalent per year.  The
                  specific sources excepted in paragraph II.1a(3)(b) are
                  also excepted for II.1a(4)(a).

             (b)  Justification for Increase of Public Dose Limit.  A
                  request to EH-1 for a dose limit higher than 100 mrem
                  (1 mSv) shall be accompanied by documentation that
                  discusses the need for the increase, the alternatives
                  considered, and the application of the ALARA process.
                  EH-1 may approve such a request, or a lesser increase in
                  the public dose limit, as appropriate.

    b.  Airborne Emissions Only, All DOE Sources of Radionuclides.  To the
        extent required by the Clean Air Act, the exposure of members of
        the public to radioactive materials released to the atmosphere as
        a consequence of routine DOE activities shall not cause members of
        the public to receive, in a year, an effective dose equivalent
        greater than 10 mrem (0.1 mSv).  Exposures to, and releases of,
        radon-220, radon-222, and their respective decay products are
        subject to DOE limits (See Figure III-3 and paragraphs IV.4b and
        IV.6).

        (1)  Title 40 CFR Part 61.  The public dose limits as outlined in
             paragraph II.1b are established by EPA regulation 40 CFR Part
             61, Subpart H, under the authority of the Clean Air Act.
             These limits apply offsite where the members of the public
             reside or abide.  Subparts Q and T provide radon flux limits
             for DOE radium storage and disposal facilities (Chapter IV)
             and DOE inactive uranium mill tailings sites regulated under
             40 CFR Part 192.

        (2)  AIRDOS/RADRISK Codes.  To demonstrate compliance analytically
             with air emissions for the Clean Air Act Standards, doses to
             the individuals shall be evaluated using the version of
             AIRDOS/RADRISK known as CAP-88 or, when available and approved,
             AIRDOS-PC.  Other computer codes or models, such as "Comply
             Code," which are specifically approved in accordance with 40
             CFR Part 61, may also be used.

        (3)  Environmental Measurements.  Compliance may also be
             demonstrated through environmental or effluent measurements
             using EPA-approved techniques.  In this case, the doses
             estimated are to individuals in areas offsite, where they are
             assumed to reside at the point of maximum annual air
             concentration.

    c.  All Exposure Modes, Sources from Management and Storage of Spent
        Nuclear Fuel, High-Level, and Transuranic Wastes at Disposal
        Facilities.  To the extent required by 40 CFR Part 191, the
        exposure of members of the public to direct radiation or
        radioactive material released from DOE management and storage
        activities at a disposal facility for spent nuclear material or
        for high-level or transuranic radioactive wastes that are not
        regulated by the NRC shall not cause members of the public to
        receive, in a year, a dose equivalent greater than 25 mrem (0.25
        mSv) to the whole body or a committed dose equivalent greater than
        75 mrem (0.75 mSv) to any organ.

        (1)  40 CFR Part 191.  The dose limits as outlined in paragraph
             II.1c, are established by Section 191.03(b) of EPA regulation
             40 CFR Part 191, Subpart A, "Environmental Standards for
             Management and Storage."  The implementation of the
             requirements of Subpart B, "Environmental Standards for
             Disposal," is beyond the scope of this Order.  DOE waste
             management and storage activities at facilities other than
             disposal facilities are subject to the dose limits outlined
             in paragraph II.1c.  The Waste Isolation Pilot Plant, for
             purposes of this Order, is considered to be a disposal facility
             subject to this Order and 40 CFR Part 191.  Other requirements
             and guidelines for the management and storage of spent nuclear
             fuel and high-level and transuranic waste at DOE facilities
             that are not licensed by the NRC are given in DOE 5820.2A.

        (2)  Regulatory Requirements.  DOE facilities and operations, in
             some instances, are subject to the regulatory requirements of
             the NRC and the EPA, e.g., 10 CFR Parts 60 and 72 and 40 CFR
             Parts 61, 191, and 192.  It is Departmental policy that DOE
             facilities and operations will comply fully with the
             requirements of those and other applicable regulatory
             requirements.  In addition, these same DOE facilities and
             operations shall comply with all applicable requirements in
             this Order unless they are duplicative or conflict with any
             of the other Federal regulatory requirements.  The resolution
             of issues concerning duplicative or conflicting requirements
             will be conducted pursuant to the issue coordination provisions
             of DOE 5400.2A.

        (3)  Evaluation of Exposure Modes.  Dose conversion factors that
             provide dose estimates for exposure to concentrations of
             specific radionuclides in air and water and selected exposure
             modes are provided in the documents Federal Guidance Report
             No. 11 (EPA-520/1-88-020), DOE/EH-0070 and DOE/EH-0071.  Use
             of these factors is discussed in paragraph II.6b.

    d.  Drinking Water Pathway Only, All DOE Sources of Radionuclides.  It
        is the policy of DOE to provide a level of protection for persons
        consuming water from a public drinking water supply operated by
        the DOE, either directly or through a DOE contractor, that is
        equivalent to that provided to the public by the public community
        drinking water standards of 40 CFR Part 141.  These systems shall
        not cause persons consuming the water to receive an effective dose
        equivalent greater than 4 mrem (0.04 mSv) in a year.  Combined
        radium-226 and radium-228 shall not exceed 5x10-9 micro Ci/ml and
        gross alpha activity (including radium-226 but excluding radon and
        uranium) shall not exceed 1.5x10-8 micro Ci/ml.

        (1)  DOE Drinking Water Systems.  The dose limit is consistent with
             the drinking water criteria in 40 CFR Part 141, "National
             Interim Primary Drinking Water Regulations (Safe Drinking Water
             Act)."

        (2)  Dose Components.  The dose limit is the effective dose
             equivalent to individuals whose exclusive source of drinking
             water contains a radionuclide, or a mixture of radionuclides,
             at a monthly average level of four percent of the appropriate
             DCG value.  For simplicity, it is assumed that site workers
             are also exposed to four percent of DCG values or the radium
             and gross alpha levels in II.1d for drinking water while away
             from the DOE site.

        (3)  Impact on Other Systems.  The liquid effluents from DOE
             activities shall not cause private or public drinking water
             systems downstream of the facility discharge to exceed the
             drinking water radiological limits in 40 CFR Part 141.

2.  THE ALARA PROCESS.  Field Elements shall develop a program and shall
    require contractors to implement the ALARA Process for all DOE
    activities and facilities that cause public doses.

    a.  Considerations.  ALARA requires judgment with respect to what is
        reasonably achievable.  Factors that relate to societal,
        technological, economic, and other public policy considerations
        shall be evaluated to the extent practicable in making such
        judgments.  Factors to be considered, at a minimum, shall include:

        (1)  The maximum dose to members of the public;

        (2)  The collective dose to the population;

        (3)  Alternative processes, such as alternative treatments of
             discharge streams, operating methods, or controls;

        (4)  Doses for each process alternative;

        (5)  Costs for each of the technological alternatives;

        (6)  Examination of the changes in cost among alternatives;

        (7)  Changes in societal impact associated with process
             alternatives, e.g., differential doses from various pathways.

    b.  Evaluations.  A quantitative cost-benefit analysis (e.g.,
        optimization) could be performed, given the results of the
        considerations noted in paragraph II.2a, above.  However, the
        parameters needed to evaluate the cost-benefit analyses are
        difficult to quantify, and evaluations themselves can be expensive.
        Furthermore, the evaluations include many additional assumptions,
        judgment, and limitations that are often difficult to reflect as
        uncertainties in the analyses.  Therefore, except for meeting
        requirements of the National Environmental Policy Act, qualitative
        analyses are acceptable, in most instances, for ALARA judgments,
        especially where potential doses are well below the dose limit.  The
        bases for such judgments should be documented.  More detailed
        analyses should be considered if the decisions might result in doses
        that approach the limit.

3.  MANAGEMENT AND CONTROL OF RADIOACTIVE MATERIALS IN LIQUID DISCHARGES
    AND PHASEOUT OF SOIL COLUMNS.  In addition to the requirement to limit
    dose to members of the public (onsite or offsite) in accordance with
    the standards established in paragraphs 11.1a and II.1d, further
    controls are imposed on liquid releases to protect resources such as
    land, surface water, ground water, and the related ecosystems from
    undue contamination.  DCGs are not release limits, but rather are
    screening values for considering BAT for these discharges and for
    making dose estimates.  The following requirements apply at the point
    of discharge from the conduit to the environment.

    a.  Discharges of Liquid Waste to Surface Waters.

        (1)  Discharge at Greater Than DCG Level.  For liquid wastes
             containing radionuclides from DOE activities which are
             discharged to surface water, the best available technology
             (BAT) is the prescribed level of treatment if the surface
             waters otherwise would contain, at the point of discharge and
             prior to dilution, radioactive material at annual average
             concentrations greater than the DCG values in liquids given
             in Chapter III.  The BAT selection process shall be implemented
             in accordance with II.3a(1)(a) and (b), below.  Although there
             is no known practicable method for removing tritium from liquid
             waste streams, facilities and operations are to be designed and
             operated so that tritium sources and releases are considered in
             the ALARA process.

             (a)  BAT Selection.  Selection of the best available technology
                  for a specific application will be made from among
                  candidate alternative treatment technologies which are
                  identified by an evaluation process that includes factors
                  related to technology, economics, and public policy
                  considerations.  Factors that are to be considered in
                  selecting BAT, at a minimum, shall include:

                  1  the age of equipment and facilities involved;

                  2  the process employed;

                  3  the engineering aspects of the application of
                     various types of control techniques;

                  4  process changes;

                  5  the cost of achieving such effluent reduction;

                  6  non-water quality environmental impact (including
                     energy requirements);

                  7  safety considerations; and

                  8  public policy considerations.

                  BAT analyses are difficult to express quantitatively
                  because the factors do not have a common denominator.
                  However, consideration of the factors will permit
                  qualitative evaluations which will support judgments.

             (b)  Plan and Schedule for Implementation.  A plan and schedule
                  to install waste treatment systems in existing facilities,
                  if justified by a BAT analysis, shall be developed within
                  6 months of the issuance date of this Order, to permit
                  compliance with paragraph II.3a(1) at the earliest
                  practicable time.  The plan shall include an ALARA section
                  on tritium, where applicable.  General design criteria are
                  presented in DOE 6430.1A.

             (c)  Approval.  The plan shall be submitted for approval to
                  the responsible DOE Field Office Manager and updated
                  annually, consistent with the provisions of DOE 5820.2A
                  for preparing and updating Waste Management Plans.

        (2)  Discharge at Less Than DCG Level.  Implementation of the BAT
             process for liquid radioactive wastes is not required where
             radionuclides are already at a low level, i.e., the annual
             average concentration is less than DCG level.  In that case,
             the cost consideration component of BAT analysis precludes the
             need for additional treatment, since any additional treatment
             would be unjustifiable on a cost-benefit basis.  Therefore,
             additional treatment will not be required for waste streams
             that contain radionuclide concentrations of not more than the
             DCG values in Chapter III at the point of discharge to a
             surface waterway.  However, the ALARA provisions are
             applicable.

        (3)  Multiple Radionuclides.  For purposes of II.3a(1), above, the
             DCG for liquid waste streams containing more than one type of
             radionuclide shall be the sum of the fractional DCG values.

        (4)  Sedimentation.  To prevent the buildup of radionuclide
             concentrations in sediments, liquid process waste streams
             containing radioactive material in the form of settleable
             solids may be released to natural waterways if the
             concentration of radioactive material in the solids present
             in the waste stream does not exceed 5 pCi (0.2 Bq) per gram
             above background level, of settleable solids for alpha-emitting
             radionuclides or 50 pCi (2 Bq) per gram above background level,
             of settleable solids for beta-gamma-emitting radionuclides.

        (5)  Interim Dose Limit for Native Aquatic Animal Organisms.  To
             protect native animal aquatic organisms, the absorbed dose to
             these organisms shall not exceed 1 rad per day from exposure to
             the radioactive material in liquid wastes discharged to natural
             waterways.  DOE publication DOE/EH-0173T provides guidance on
             monitoring and calculating dose for aquatic organisms.

        (6)  New Facilities.  New facilities shall be designed and
             constructed to meet the discharge requirements shown in
             paragraph 11.3a.

    b.  Discharges of Liquid Waste to Aquifers and Phaseout of Soil Columns.

        (1)  Phasing Out the Use of Soil Columns.  The use of soil columns
             (i.e., trenches, cribs, ponds, and drain fields) to retain, by
             sorption or ion exchange, suspended or dissolved radionuclides
             from liquid waste streams shall be discontinued at the earliest
             practicable time in favor of an acceptable alternative disposal
             means.  DOE activities that currently discharge liquids
             containing radioactive materials not first treated by BAT to
             soil columns, shall develop, within 6 months of the issuance
             date of this Order, a plan and schedule for implementing
             alternate acceptable disposal at the earliest practicable time.
             The BAT selection process shall be applied to those liquid
             waste streams that will continue to be discharged to soil
             columns for indefinite periods and which contain
             process-derived radionuclides.  The plan shall be submitted for
             approval to the respective DOE Field Office Manager and updated
             annually, consistent with the provisions of DOE 5820.2A for
             preparing and updating Waste Management Plans.

        (2)  Prohibition of New or Increased Discharge Quantities and New
             Soil Columns.  Except as permitted by the provisions in
             paragraph II.3e(1), new or increased discharges of
             radionuclides in liquid waste to active soil columns and
             virgin soil columns shall be prohibited after the effective
             date of this Order.

    c.  Management of Soil Columns, Natural Drainage Systems, and Ground
        Water at Inactive Sites Previously Contaminated with Radioactive
        Material.

        (1)  Inactive Receptors.  Contaminated soil columns, drainage
             systems, and ground water to which contaminated liquid
             discharges have been discontinued shall be managed or
             decontaminated pursuant to the procedures and requirements
             of DOE 5480.4 and in the 5400 series.

        (2)  Discharge of Other Liquids.  Liquid discharges, even though
             uncontaminated, are prohibited in inactive release areas to
             prevent the further spread of radionuclides previously
             deposited.

    d.  Discharges of Liquid Waste to Sanitary Sewerage.  The BAT selection
        process shall be implemented if liquid wastes discharged from DOE
        activities into sanitary sewerage contain radionuclides at
        concentrations, averaged monthly, would otherwise be greater than
        five times the DCG values for liquids given in Chapter III at the
        point of discharge.  That is, the BAT selection process shall be
        implemented if the total of the fractions of the average
        concentrations for each radionuclide to its respective DCG value
        would otherwise exceed 5.

        (1)  Discharges to public sewers should be coordinated with the
             operators of the waste water treatment works.

        (2)  Concentrations shall be controlled so that long-term buildup
             of radionuclides in solids will not present a handling and
             disposal problem at sewage disposal plants.

        (3)  Liquid wastes containing concentrations or quantities of
             radioactive materials that, when averaged monthly, are
             greater than those specified in paragraph II.3d may be
             discharged into a chemical or sanitary sewerage system (e.g.,
             systems with drain fields excepted) if the system is owned by
             the Federal Government.  However, ALARA process considerations
             are required.  Such a sewerage system will provide liquid waste
             treatment prior to discharge to surface waters in accordance
             with the requirements of paragraph II.3a(1).

        (4)  Operators should ensure that the total annual discharge of
             radioactive material to the sanitary sewer system will not
             cause exposures to members of the general public that will
             result in doses exceeding a small fraction of the basic
             annual dose limit.

    e.  Exceptions for Liquid Waste Control Requirements.

        (1)  Interim Control Strategies.  DOE Field Office Managers
             responsible for DOE activities that cannot comply, when this
             Order is issued, with requirements shown in paragraph II.3,
             shall develop an interim control strategy with adequate
             documentation identifying the alternatives considered and
             evaluations thereof.  Such interim control strategies shall be
             adopted and implemented under the provisions of DOE 5820.2A,
             Chapter III, paragraph 3a(2), within 6 months of the issuance
             of this Order, and shall be reevaluated every two years
             thereafter.

        (2)  Tritium Control.  There is no practicable technology available
             for removing tritium from dilute liquid waste streams.
             Therefore, process alternatives that reduce the amount of
             tritium entering the liquid waste streams shall be identified
             and evaluated in accordance with the DOE ALARA policy.  Tritium
             decay in transit in confined ground water may be an acceptable
             alternative to direct release to the atmosphere or to surface
             waters.  A description and summary of the alternatives
             considered in the control of tritium releases shall be
             incorporated into the site Waste Management Plan required by
             DOE 5820.2A.

4.  MANAGEMENT OF LOW-LEVEL RADIOACTIVE SOLID WASTE.  The requirements for
    the management of low-level wastes are presented in DOE 5400.1 and DOE
    5820.2A.  Design, operational, and monitoring requirements for disposal
    of solid low-level waste containing no constituents regulated by The
    Resource Conservation and Recovery Act (RCRA) are addressed in DOE
    5820.2A.

5.  RELEASE OF PROPERTY HAVING RESIDUAL RADIOACTIVE MATERIAL.

    a.  Release of Real Property.  Release of real property (land and
        structures) shall be in accordance with the guidelines and
        requirements for residual radioactive material presented in
        Chapter IV.  These guidelines and requirements apply to both
        DOE-owned facilities and to private properties that are being
        prepared by DOE for release.  Real properties owned by DOE that
        are being sold to the public are subject to the requirements of
        Section 120(h) of the Comprehensive Environmental Response
        Compensation and Liability Act (CERCLA), as amended, concerning
        hazardous substances, and to any other applicable Federal, State,
        and local requirements.  The requirements of 40 CFR Part 192 are
        applicable to properties remediated by DOE under Title I of the
        Uranium Mill Tailings Radiation Control Act (UMTRA).

    b.  Release of Personal Property.  Personal property, which potentially
        could be contaminated, may be released for unrestricted use if the
        results of a survey with appropriate instruments indicate that the
        property is less than the contamination limits presented in Figure
        IV-1.

    c.  Release of Materials and Equipment.

        (1)  Surface Contamination Levels.  Prior to being released,
             property shall be surveyed to determine whether both removable
             and total surface contamination (including contamination
             present on and under any coating) are in compliance with the
             levels given in Figure IV-1 and that the contamination has been
             subjected to the ALARA process.

        (2)  Potential for Contamination.  Property shall be considered to
             be potentially contaminated if it has been used or stored in
             radiation areas that could contain unconfined radioactive
             material or that are exposed to beams of particles capable of
             causing activation (neutrons, protons, etc.).

        (3)  Surveys.  Surfaces of potentially contaminated property shall
             be surveyed using instruments and techniques appropriate for
             detecting the limits stated in Figure IV-1.

        (4)  Inaccessible Areas.  Where potentially contaminated surfaces
             are not accessible for measurement (as in some pipes, drains,
             and ductwork), such property may be released after case-by-case
             evaluation and documentation based on both the history of its
             use and available measurements demonstrate that the
             unsurveyable surfaces are likely to be within the limits given
             in Figure IV-1.

        (5)  Records.  The records of released property shall include:

             (a)  A description or identification of the property;

             (b)  The date of the last radiation survey;

             (c)  The identity of the organization and the individual who
                  performed the monitoring operation;

             (d)  The type and identification number of monitoring
                  instruments;

             (e)  The results of the monitoring operation; and

             (f)  The identity of the recipient of the released material.

        (6)  Volume Contamination.  No guidance is currently available for
             release of material that has been contaminated in depth, such
             as activated material or smelted contaminated metals (e.g.,
             radioactivity per unit volume or per unit mass).  Such
             materials may be released if criteria and survey techniques
             are approved by EH-1.

6.  DEMONSTRATION OF COMPLIANCE WITH THE DOSE LIMITS.  Compliance with the
    dose limits of this Order shall be demonstrated by documentation of an
    appropriate combination of measurements and calculations to evaluate
    potential doses and the results of the evaluations.

    a.  Monitoring and Surveillance.  General requirements for routine
        effluent monitoring are part of the environmental monitoring plan
        prescribed in DOE 5400.1.  Specific requirements for radiological
        effluent monitoring and environmental surveillance and their
        schedule of implementation are prescribed in DOE publication DOE/
        EH-0173T which deal with radiological effluent monitoring and
        environmental surveillance.  The monitoring requirements are
        applicable to all DOE and DOE contractor operations that are
        subject to the standards and requirements of this Order.

    b.  Dose Evaluations.  Doses to members of the public in the vicinity
        of DOE activities shall be evaluated and documented to demonstrate
        compliance with the dose limits of this Order and to assess
        exposures of the public from unplanned events.  Collective doses
        to the public within 80 km of the site shall also be evaluated and
        documented at least annually.

        (1)  Modeling.  Analytical models used for dose evaluations shall
             be appropriate for characteristics of emissions (e.g., gas,
             liquid, or particle; depositing or nondepositing; buoyant or
             non-buoyant); mode of release (e.g., stack or vent; crib or
             pond; surface water or sewer; continuous or intermittent);
             environmental transport medium (e.g., air or water); and
             exposure pathway (e.g., inhalation; ingestion of food, water,
             or milk; direct radiation).  Information on dispersion
             (transport and diffusion) in the environment, demography,
             land use (including the location and number of dairy and
             slaughter animals), food supplies, and exposure pathways used
             in the dose calculations shall be appropriate to evaluate
             actual and potential doses in the environs of DOE facilities.
             Such information shall be updated as necessary to document
             significant changes that could affect dose evaluations.  Dose
             evaluation models that are codified, approved, or accepted by
             regulatory or other authorities shall be used where
             appropriate, such as the AIRDOS/RADRISK codes for demonstrating
             compliance with 40 CFR Part 61, Subpart H.

        (2)  Dose Conversion Factors.  Except as provided in paragraph
             II.6b(2)(d), tables of approved dose conversion factors in
             paragraphs II.6b(2)(a), (b), and (c), below, shall be used to
             evaluate doses unless otherwise legally required, e.g., use
             of AIRDOS/RADRISK codes pursuant to 40 CFR Part 61, Subpart H.

             (a)  Committed Dose Conversion Factors.  Radionuclides taken
                  into the body, generally by exposure modes whereby the
                  radionuclide is ingested or inhaled, will continue to
                  irradiate the body as long as they exist and are retained
                  by the body.  The dose delivered to a body over the
                  lifetime of the individual from a single committed dose
                  conversion factors shall be used, as appropriate, and are
                  presented in EPA-520/1-88-020, Federal Guidance Report No.
                  11, "Limiting Values of Radionuclide Intake and Air
                  Concentration and Dose Conversion Factors for Inhalation,
                  Submersion, and Ingestion," and in DOE/EH-0071, "Internal
                  Dose Conversion Factors for Calculation of Dose to the
                  Public."  These conversion factors are based upon the ICRP
                  reference man model, and the committed dose is the dose
                  integrated over an interval of 50 years.

             (b)  External Dose Conversion Factors.  The doses from exposure
                  to external radiation from radionuclide concentrations in
                  air and in water that result from submersion or from
                  exposure to contaminated plane surfaces shall be
                  estimated, as appropriate, using the external dose
                  conversion factors presented in EPA-520/1-88-020, Federal
                  Guidance Report No. 11, "Limiting Values of Radionuclides
                  Intake and Air Concentration and Dose Conversion Factors
                  for Inhalation, Submersion, and Ingestion" and in
                  DOE/EH-0070, "External Dose-Rate Conversion Factors for
                  Calculation of Dose to the Public."

             (c)  Derived Concentration Guides (DCG).  DCG values are
                  presented as reference values in Chapter III for each of
                  three exposure modes:  inhalation of air containing the
                  radionuclide; submersion in a semi-infinite cloud of air
                  containing the radionuclide; and ingestion of water
                  containing the radionuclide.  The DCG tables may be used
                  to evaluate only the three exposure modes upon which
                  they are based.

             (d)  Other Methods and Alternatives.  Methods and alternatives
                  other than those discussed above and as prescribed in
                  applicable regulations shall be submitted to EH-1 for
                  approval.  EH-1 may approve the alternative method, if
                  appropriate.

        (3)  Parametric Considerations.

             (a)  Dose limits for members of the general public, from
                  routine operation of a DOE activity, shall be expressed
                  as a dose received by the individuals during the year
                  (if, for example, the exposure is external to the body)
                  or the committed dose received by the individual over a
                  period of 50 years from radionuclides taken into the
                  body during the year.  The limits should not be
                  interpreted as dose rates per se, especially not in the
                  sense of instantaneous dose rates.

             (b)  Doses calculated should be as realistic as practicable.
                  Consequently, the individuals subject to the greatest
                  exposure shall be identified, to the extent practicable,
                  so that the highest dose might be determined.

             (c)  Dose limits apply to actual or committed doses to real
                  individuals.  Consequently, all factors germane to dose
                  determination should be applied.  Alternatively, if
                  available data are not sufficient to evaluate these
                  factors or if they are too costly to determine, the
                  assumed parametric values shall be sufficiently
                  conservative so that it is unlikely that individuals
                  would actually receive a dose that would exceed the dose
                  calculated using the values assumed.

             (d)  Parametric values used in performing dose calculations
                  shall be recorded.

             (e)  Collective public dose in the environs of a site with
                  multiple emission points may be estimated using the
                  assumption that all emissions occur from a single point
                  centrally located on the site.  Guidance on combining
                  emission points is provided in EPA-450/477-001,
                  "Guidelines for Air Quality Maintenance Planning and
                  Analysis," Vol. 10, Revised:  Procedures for Evaluating
                  Air Quality Impact of New Stationary Sources.

             (f)  The assumption of a single point of emission, as discussed
                  in II.6b(3)(e), may be used to calculate public dose for
                  the maximally exposed individuals if the emission points
                  are close to one another relative to the distance to the
                  site boundary.  Otherwise, the public dose to the
                  maximally exposed individuals should be determined taking
                  into consideration the actual locations of emissions on
                  the site with respect to the offsite locations.

7.  REPORTING REQUIREMENTS.  In addition to the reporting requirements of
    DOE 5400.1 and DOE 5484.1, the responsible DOE Field Office Manager
    shall notify, in a timely manner, the relevant Program Office(s) and the
    Deputy Assistant Secretary for Environment (EH-20) of actual or
    potential exposures of members of the public that could result in
    either an effective dose equivalent from DOE sources exceeding 10 mrem
    (0.1 mSv) in a year; or exceeding any limit or not meeting any other
    requirement specified in this Order or any other legally applicable
    limits, or a combined dose equal to or greater than 100 mrem (1 mSv)
    effective dose equivalent in a year due to DOE and other man-made
    sources of radiation (medical, consumer products, and natural sources
    excepted).  For purposes of determining compliance with the reporting
    requirements of 40 CFR Parts 302 and 355, releases of source,
    by-product, and special nuclear material that occur from DOE activities
    are considered to be "Federally permitted" releases if they do not
    exceed the limits specified in this Order  and the operations and
    releases are in compliance with DOE policies, and guidelines, and
    requirements specified in DOE Orders, including DOE 5820.2A.

8.  RECORDS.

    a.  Content.  Records developed shall include information and data
        necessary to identify and characterize releases of radioactive
        material to the environment, their fate in the environment, and
        their probable impact on radiation doses to the public.  Basic
        information used assess compliance with the requirements of this
        Order pursuant to paragraph 11.6, and the results of such
        assessments, shall be incorporated as part of the record.

    b.  Retention.  Information and data developed pursuant to this Order
        shall be retained consistent with the requirements of DOE 1324.2A
        and other legally applicable requirements.

9.  UNITS.  All reports, notifications, and records developed pursuant to
    DOE Order requirements shall present data in the units used in the
    applicable regulation or DOE Order.



                                CHAPTER III

                       DERIVED CONCENTRATION GUIDES
                             FOR AIR AND WATER

1.  PURPOSE.  The Derived Concentration Guide (DCG) values listed in this
    chapter are provided as reference values for conducting radiological
    environmental protection programs at operational DOE facilities and
    sites.  Derived Air Concentrations (DAC) guides for controlling
    occupational intake of radionuclides through inhalation are listed in
    DOE 5480.11.

2.  BASIS.  The DCG values are presented for each of three exposure modes:
    1) ingestion of water; 2) inhalation of air; and 3) immersion in a
    gaseous cloud.  The DCG values for internal exposure shown in Figure
    III-1 are based on a committed effective dose equivalent of 100 mrem
    for the radionuclide taken into the body by ingestion or inhalation
    during one year.  To use the DCGs for comparison with the DOE drinking
    water systems criterion of 4 mrem/yr (0.04 mSv/yr), use 4 percent of
    the DCG values for ingestion.  Compliance with the 40 CFR Part 61,
    Subpart H, criterion of 10 mrem/yr (0.10 mSv/yr) effective dose
    equivalent is demonstrated using the AIRDOS/RADRISK models prescribed
    by the EPA.  Alternative gastrointestinal-tract (GI-tract) absorption
    factors (f1) and lung retention classes (noted as D, W, or Y in the
    Task Group Lung Model used to produce the inhalation dose factors
    reported in ICRP Publication 30) are listed for specific compounds, by
    element, in Figure III-2 for cross-referencing with the internal DCGs
    in Figure III-1.  The data in Figure III-2 are listed in alphabetical
    order, by element name.  Removal half-times assigned to the compounds
    with lung retention classes D, W, and Y are 0.5, 50, and 500 days,
    respectively.  The air immersion DCG values shown in Figure III-3 are
    based on an effective dose equivalent of 100 mrem from exposure during
    one year.  Figure III-1 contains six columns of information:
    Radionuclide/Chemical Form/Isomer Half-Life; f1 Value (GI-tract
    absorption); Ingested Water DCG (  Ci/mL); Inhaled Air DCG for Lung
    Retention Class D (  Ci/mL); and Inhaled Air DCG for Lung Retention
    Class W (  Ci/mL); and Inhaled Air DCG for Lung Retention Class Y
    (  Ci/mL).  Figure III-2 contains five columns of information:
    Element/Symbol; Atomic Number; compound; f1 value; and Lung Retention
    Class.  Figure III-3 contains three columns of information:
    Radionuclide; Half-life in units of seconds (s), minutes (min), hours
    (h), days (d), or years (yr); and Air Immersion DCG (  Ci;mL).

    a.  Exposure Conditions for Ingestion of Water and Inhalation.  Under
        conditions of continuous exposure, members of the public are
        assumed to ingest 730 liters of drinking water or to inhale 8,400
        cubic meters of air (for exposure of 24 hours per day, 365 days
        per year), as given for the "reference man" in ICRP Publication
        23.  Only single modes of exposure were considered in the
        calculation of the DCGs - that is, they apply to either inhalation
        or ingestion, not to a combination of both.  The dose factors used
        to calculate the DCG values for internal exposure were taken from
        the report "Internal Dose Conversion Factors for Calculation of
        Dose to the Public" (DOE/EH-0071).  For ingestion, DCG values are
        tabulated for all values of f1 for each radionuclide given in ICRP
        Publication 30, as modified for several transuranic elements by
        ICRP Publication 48.  For inhalation, DCG values are given for all
        combinations of f1 and lung retention class (D, in, or Y) given by
        the ICRP, as tabulated in Figure III-2.  For radionuclides with
        multiple f1 listings, where specific data for an airborne or
        liquid release are lacking, the f1 value that results in the most
        restrictive DCG for ingested water or inhaled air should be used.

    b.  Exposure Conditions for Air Immersion.  The air immersion DCGs were
        calculated for a continuous, nonshielded exposure via immersion in a
        semi-infinite atmospheric cloud.  The dose conversion factors used
        to calculate the DCG values for air immersion were taken from the
        report "External Dose-Rate Conversion Factors for Calculation of
        Dose to the Public" (DOE/EH-0070).  The DCG value for air immersion
        listed in Figure III-3 for a given radionuclide is determined either
        by a limit on annual effective dose equivalent, which provides a
        limit on stochastic radiation effects, or by a limit on annual dose
        equivalent to any organ, which provides a limit on nonstochastic
        radiation effects.  For most of the radionuclides listed in Figure
        III-3, the DCG value is determined by the limit on annual effective
        dose equivalent.  Thus, the few cases where the DCG value is
        determined by the limit on annual dose equivalent to skin are
        indicated in the figure by an appropriate footnote.  Again, the DCGs
        listed in Figure III-3 account only for immersion in a semi-infinite
        cloud and do not account for inhalation or ingestion exposures.
        Three classes of radionuclides are included in the air immersion
        DCGs given in Figure III-3, as described below.

        (1)  Class 1.  The first class of radionuclides includes selected
             noble gases and short-lived activation products that occur in
             gaseous form.  For these radionuclides, inhalation doses are
             negligible compared to the external dose from immersion in an
             atmospheric cloud.

        (2)  Class 2.  The second class of radionuclides includes those
             for which a DCG value for inhalation has been calculated
             (using the ICRP inhalation dose equivalent factors), but for
             which the DCG value for external exposure to a contaminated
             atmospheric cloud is more restrictive (i.e., results in a
             lower DCG value).  These radionuclides generally have
             half-lives of a few hours or less, or are eliminated from the
             body following inhalation sufficiently rapidly to limit the
             inhalation dose.

        (3)  Class 3.  The third class of radionuclides includes selected
             isotopes with relatively short half-lives that were not
             considered in ICRP Publication 30.  These radionuclides
             typically have half-lives that are less than 10 minutes, they
             do not occur as a decay product of a longer-lived radionuclide,
             or they lack sufficient decay data to permit internal dose
             calculations.  These radionuclides are also typified by a
             radioactive emission of highly intense, high-energy photons and
             rapid removal from the body following inhalation.

    c.  Application to Mixtures of Radionuclides.  The DCG values are given
        for individual radionuclides.  For known mixtures of radionuclides,
        the sum of the ratios of the observed concentration of each
        radionuclide to its corresponding DCG must not exceed 1.0.

3.  LIMITATIONS.  The values given in Figures III-1 and III-3 account for
    only three exposure pathways (ingested water or inhaled air or air
    immersion) and do not include other potentially significant pathways.
    When more complex environmental pathways are involved, a more complete
    pathway analysis is required for calculating public radiation doses
    resulting from the operation of DOE facilities.

                         Ingested         Inhaled Air DCG (uCi/mL)
                f 1/     Water DCG      -----------------------------
Radionuclide   Value     (uCi/mL)           D         W        Y
------------   -----     ---------      --------- --------- ---------
H-3 (Water)              2.E-03           1/      1.E-07 2/
H-3 (Elemental)                                   2.E-02 2/

Be-7           5.E-03    1.E-03                   5.E-08    4.E-08
Be-10          5.E-03    3.E-O5                   4.E-10    3.E-11

C-11 (Org)               1.E-02                   1.E-06
C-11 (CO)                               3.E-06
C-11 (CO2)                              1.E-06
C-14 (Org)               7.E-02                   6.E-09
C-14 (CO)                               4.E-06
C-14 (CO2)                              5.E-07

F-18 3/        1.E+00    1.E-03         2.E-07    2.E-07    2.E-07

Na-22          1.E+00    1.E-05         1.E-09
Na-24 3/       1.E+00    1.E-04         1.E-08

Mg-28          5.E-01    2.E-05         4.E-09    3.E-09

Al-26          1.E-02    1.E-05         1.E-10    2.E-10

Si-31          1.E-02    3.E-04         6.E-08    7.E-08    6.E-08
Si-32          1.E-02    8.E-05         6.E-10    3.E-10    1.E-11
P-32           8.E-01    2.E-05         2.E-09    9.E-10
P-33           8.E-01    2.E-04         2.E-08    6.E-09

S-35           8.E-01    3.E-04         4.E-08    5.E-09
               1.E-01    2.E-04
S-35 (Gas)                              3.E-08

Cl-36 3/       1.E+00    5.E-05         6.E-09    6.E-10
Cl-38          1.E+00    7.E-04         1.E-07    1.E-07
Cl-39          1.E+00    1.E-03         1.E-07    1.E-07

K-40           1.E+00    7.E-06         9.E-10
K-42           1.E+00    1.E-04         1.E-08
K-43 3/        1.E+00    2.E-04         2.E-08
K-44           1.E+00    9.E-04         2.E-07

                          Figure III-1
   Derived Concentration Guides (DCGs) for Members of the Public from
          Ingested Water and Inhalation Resulting in 100 mrem/yr

                         Ingested         Inhaled Air DCG (uCi/mL)
                f 1/     Water DCG      -----------------------------
Radionuclide   Value     (uCi/mL)           D         W        Y
------------   -----     ---------      --------- --------- ---------
K-45           1.E+00    1.E-03         3.E-07

Ca-41          3.E-01    1.E-04                   9.E-09
Ca-45          3.E-01    5.E-05                   2.E-09
Ca-47          3.E-01    2.E-05                   2.E-09

Sc-43          1.E-04    2.E-04                             5.E-08
Sc-44m         1.E-04    1.E-05                             2.E-09
Sc-44 3/       1.E-04    1.E-04                             3.E-08
Sc-46          1.E-04    2.E-05                             6.E-10
Sc-47          1.E-04    7.E-05                             7.E-09
Sc-48          1.E-04    2.E-05                             3.E-09
Sc-49          1.E-04    6.E-04                             1.E-07

Ti-44          1.E-02    7.E-06         3.E-11    7.E-11    1.E-11
Ti-45 3/       1.E-02    2.E-04         6.E-08    8.E-08    7.E-08

V-47           1.E-02    9.E-04         2.E-07    2.E-07
V-48           1.E-02    2.E-05         3.E-09    2.E-09
V-49           1.E-02    3.E-03         8.E-08    4.E-08

Cr-48          1.E-01    2.E-04         3.E-08    2.E-08    2.E-08
               1.E-02    2.E-04
Cr-49 3/       1.E-01    8.E-04         2.E-07    2.E-07    2.E-07
               1.E-02    8.E-04
Cr-51          1.E-01    1.E-03         1.E-07    6.E-08    5.E-08
               1.E-02    1.E-03

Mn-51          1.E-01    6.E-04         1.E-07    1.E-07
Mn-52m 3/      1.E-01    9.E-04         2.E-07    2.E-07
Mn-52          1.E-01    2.E-05         3.E-09    2.E-09
Mn-53          1.E-01    1.E-03         6.E-08    3.E-08
Mn-54          1.E-01    5.E-05         2.E-09    2.E-09
Mn-56 3/       1.E-01    1.E-04         4.E-08    5.E-08

Fe-52          1.E-01    3.E-05         7.E-09    6.E-09
Fe-55          1.E-01    2.E-04         5.E-09    1.E-08
Fe-59          1.E-01    2.E-05         8.E-10    1.E-09
Fe-60          1.E-01    9.E-07         2.E-11    4.E-11

Co-55          5.E-02    3.E-05                   7.E-09    6.E-09
               3.E-01    4.E-05
Co-56          5.3-02    1.E-05                   7.E-10    5.E-10

                        Figure III-1 (contd)

                         Ingested         Inhaled Air DCG (uCi/mL)
                f 1/     Water DCG      -----------------------------
Radionuclide   Value     (uCi/mL)           D         W        Y
------------   -----     ---------      --------- --------- ---------
Co-56          3.E-01    1.E-05
Co-57          5.E-02    2.E-04                   7.E-09    2.E-09
               3.E-01    1.E-04
Co-58m         5.E-02    2.E-03                   2.E-01    2.E-07
               3.E-01    2.E-03
Co-58          5.E-02    5.E-05                   3.E-09    2.E-09
               3.E-01    4.E-05
Co-60m 3/      5.E-02    4.E-02                   9.E-06    6.E-06
               3.E-01    4.E-02
Co-60          5.E-02    1.E-05                   4.E-10    8.E-11
               3.E-01    5.E-06
Co-61          5.E-02    5.E-04                   1.E-07    1.E-07
               3.E-01    6.E-04
Co-62m         5.E-02    1.E-03                   4.E-07    4.E-07
               3.E-01    1.E-03

Ni-56          5.E-02    4.E-05         5.E-09    3.E-09
Ni-56 (Vapor)                           3.E-09
Ni-57 3/       5.E-02    4.E-05         1.E-08    7.E-09
Ni-57 (Vapor)                           1.E-08
Ni-59          5.E-02    7.E-04         9.E-09    2.E-08
Ni-59 (Vapor)                           4.E-09
Ni-63          5.E-02    3.E-04         4.E-09    6.E-09
Ni-63 (Vapor)                           2.E-09
Ni-65 3/       5.E-02    2.E-04         6.E-08    7.E-08
Ni-65 (Vapor)                           4.E-08
Ni-66          5.E-02    1.E-05         4.E-09    1.E-09
Ni-66 (Vapor)                           7.E-09

Cu-60          5.E-01    8.E-04         2.E-07    3.E-07    2.E-07
Cu-61 3/       5.E-01    3.E-04         7.E-08    1.E-07    8.E-08
Cu-64          5.E-01    3.E-04         7.E-08    5.E-08    5.E-08
Cu-67          5.E-01    1.E-04         2.E-08    1.E-08    1.E-08

Zn-62          5.E-01    4.E-05                             7.E-09
Zn-63          5.E-01    7.E-04                             2.E-07
Zn-65          5.E-01    9.E-06                             6.E-10
Zn-69m         5.E-01    1.E-04                             2.E-08
Zn-69          5.E-01    2.E-03                             3.E-07
Zn-71m         5.E-01    2.E-04                             4.E-08
Zn-72          5.E-01    3.E-05                             3.E-09

Ga-65          1.E-03    2.E-03         4.E-07    5.E-07
Ga-66 3/       1.E-03    3.E-05         8.E-09              7.E-09

                        Figure III-1 (contd)

                         Ingested         Inhaled Air DCG (uCi/mL)
                f 1/     Water DCG      -----------------------------
Radionuclide   Value     (uCi/mL)           D         W        Y
------------   -----     ---------      --------- --------- ---------
Ga-67          1.E-03    2.E-04         3.E-05    2.E-08
Ga-68 3/       1.E-03    4.E-04         1.E-01    1.E-07
Ga-70          1.E-03    2.E-03         4.E-01    5.E-07
Ga-72 3/       1.E-03    3.E-05         8.E-09    7.E-09
Ga-73          1.E-03    1.E-04         4.E-08    4.E-08

Ge-66          1.E+00    7.E-04         6.E-08    5.E-05
Ge-67          1.E+00    1.E-03         2.E-07    2.E-07
Ge-68          1.E+00    1.E-04         9.E-09    2.E-10
Ge-69          1.E+00    4.E-04         4.E-05    2.E-08
Ge-71          1.E+00    1.E-02         1.E-06    1.E-07
Ge-75          1.E+00    2.E-03         2.E-07    2.E-07
Ge-77          1.E+00    2.E-04         2.E-05    1.E-08
Ge-78          1.E+00    7.E-04         5.E-08    5.E-08

As-69          5.E-01    1.E-03                   3.E-07
As-70          5.E-01    4.E-04                   1.E-07
As-71          5.E-01    1.E-04                   1.E-08
As-72          5.E-01    2.E-05                   3.E-09
As-73          5.E-01    2.E-04                   4.E-09
As-74          5.E-01    4.E-05                   2.E-09
As-76          5.E-01    3.E-05                   4.E-09
As-77          5.E-01    1.E-04                   1.E-08
As-78          5.E-01    2.E-04                   5.E-08

Se-70          8.E-01    5.E-04         9.E-08    1.E-07
               5.E-02    3.E-04
Se-73m         8.E-01    2.E-03         4.E-07    3.E-07
               5.E-02    9.E-04
Se-73 3/       8.E-01    2.E-04         3.E-08    4.E-08
               5.E-02    9.E-05
Se-75          8.E-01    2.E-05         2.E-09    1.E-09
               5.E-02    8.E-05
Se-79          8.E-01    2.E-05         2.E-09    1.E-09
               5.E-02    1.E-04
Se-81m         8.E-01    1.E-03         2.E-07    2.E-07
               5.E-02    7.E-04
Se-81          8.E-01    2.E-03         5.E-07    6.E-07
               5.E-02    2.E-03
Se-83          8.E-01    1.E-03         3.E-07    3.E-07
               5.E-02    9.E-04

Br-74m         1.E+00    6.E-04         9.E-08    1.E-07

                        Figure III-1 (contd)

                         Ingested         Inhaled Air DCG (uCi/mL)
                f 1/     Water DCG      -----------------------------
Radionuclide   Value     (uCi/mL)           D         W        Y
------------   -----     ---------      --------- --------- ---------
Br-74          1.E+00    1.E-03         2.E-07    2.E-07
Br-75          1.E+00    1.E-03         1.E-07    1.E-07
Br-76          1.E+00    1.E-04         1.E-08    1.E-08
Br-77 3/       1.E+00    4.E-04         6.E-08    5.E-08
Br-80m         1.E+00    6.E-04         4.E-08    3.E-08
Br-80 3/       1.E+00    2.E-03         4.E-07    5.E-07
Br-82 3/       1.E+00    8.E-05         1.E-08    9.E-09
Br-83          1.E+00    2.E-03         2.E-07    1.E-07
Br-84 3/       1.E+00    9.E-04         1.E-07    2.E-07

Rb-79          1.E+00    2.E-03         3.E-07
Rb-81m         1.E+00    1.E-03         8.E-07
Rb-81 3/       1.E+00    1.E-03         1.E-07
Rb-82m         1.E+00    3.E-04         4.E-08
Rb-83          1.E+00    2.E-05         2.E-09
Rb-84          1.E+00    1.E-05         2.E-09
Rb-86          1.E+00    1.E-05         2.E-09
Rb-87          1.E+00    3.E-05         4.E-09
Rb-88 3/       1.E+00    8.E-04         1.E-07
Rb-89 3/       1.E+00    2.E-03         3.E-07

Sr-80          3.E-01    3.E-02         5.E-06
               1.E-02    3.E-02                             6.E-06
Sr-81          3.E-01    1.E-04         2.E-07
               1.E-02    6.E-04                             2.E-07
Sr-83          3.E-01    8.E-05         2.E-08
               1.E-02    6.E-05                             8.E-09
Sr-85m 3/      3.E-01    6.E-03         1.E-06
               1.E-02    6.E-03                             2.E-06
Sr-85          3.E-01    7.E-05         6.E-09
               1.E-02    1.E-04                             4.E-09
Sr-87m 3/      3.E-01    1.E-03         3.E-07
               1.E-02    1.E-03                             4.E-07
Sr-89          3.E-01    2.E-05         2.E-09
               1.E-02    2.E-05                             3.E-10
Sr-90          3.E-01    1.E-06         5.E-11
               1.E-02    1.E-05                             9.E-12
Sr-91          3.E-01    6.E-05         1.E-08
               1.E-02    5.E-05                             8.E-09
Sr-92 3/       3.E-01    9.E-05         2.E-08
               1.E-02    7.E-05                             2.E-08

Y-86m          1.E-04    6.E-04                   1.E-07    1.E-07

                        Figure III-1 (contd)

                         Ingested         Inhaled Air DCG (uCi/mL)
                f 1/     Water DCG      -----------------------------
Radionuclide   Value     (uCi/mL)           D         W        Y
------------   -----     ---------      --------- --------- ---------
Y-86 3/        1.E-04    3.E-05                   8.E-09    7.E-09
Y-87           1.E-04    6.E-05                   8.E-09    7.E-09
Y-88           1.E-04    3.E-05                   6.E-10    6.E-10
Y-90m 3/       1.E-04    2.E-04                   3.E-08    3.E-08
Y-90           1.E-04    1.E-05                   2.E-09    1.E-O9
Y-91m 3/       1.E-04    4.E-03                   6.E-07    4.E-07
Y-91           1.E-04    2.E-05                   4.E-10    3.E-10
Y-92           1.E-04    7.E-05                   2.E-08    2.E-08
Y-93           1.E-04    3.E-05                   7.E-09    6.E-09
Y-94           1.E-04    8.E-04                   2.E-07    2.E-07
Y-95           1.E-04    1.E-03                   4.E-07    3.E-07

Zr-86          2.E-03    4.E-05         9.E-09    6.E-09    6.E-09
Zr-88          2.E-03    1.E-04         5.E-10    1.E-09    7.E-10
Zr-89          2.E-03    4.E-05         8.E-09    6.E-09    6.E-09
Zr-93          2.E-03    9.E-05         4.E-11    1.E-10    2.E-10
Zr-95          2.E-03    4.E-05         6.E-10    9.E-10    7.E-10
Zr-97          2.E-03    2.E-05         5.E-09    3.E-09    3.E-09

Nb-88          1.E-02    2.E-03                   5.E-07    5.E-07
Nb-89 (66 min) 1.E-02    3.E-04                   1.E-07    9.E-08
Nb-89 (122min) 1.E-02    1.E-04                   4.E-08    4.E-08
Nb-90          1.E-02    3.E-05                   6.E-09    6.E-09
Nb-93m         1.E-02    3.E-04                   3.E-09    4.E-10
Nb-94          1.E-02    3.E-05                   5.E-10    4.E-11
Nb-95m         1.E-02    7.E-05                   6.E-09    5.E-09
Nb-95          1.E-02    6.E-05                   3.E-09    3.E-09
Nb-96          1.E-02    3.E-05                   6.E-09    6.E-09
Nb-97 3/       1.E-02    6.E-04                   2.E-07    2.E-07
Nb-98          1.E-02    4.E-04                   1.E-07    1.E-07

Mo-90          8.E-01    1.E-04         2.E-08
               5.E-02    6.E-05                             1.E-08
Mo-93m         8.E-01    3.E-04         4.E-08
               5.E-02    1.E-04                             3.E-08
Mo-93          8.E-01    1.E-04         1.E-08
               5.E-02    6.E-04                             4.E-10
Mo-99          8.E-01    5.E-05         6.E-09
               5.E-02    3.E-05                             3.E-09
Mo-101 3/      8.E-01    2.E-03         3.E-07
               5.E-02    1.E-03                             4.E-07

Tc-93m         8.E-01    2.E-03         4.E-07    7.E-07

                        Figure III-1 (contd)

                         Ingested         Inhaled Air DCG (uCi/mL)
                f 1/     Water DCG      -----------------------------
Radionuclide   Value     (uCi/mL)           D         W        Y
------------   -----     ---------      --------- --------- ---------
Tc-93          8.E-01    8.E-04         2.E-07    2.E-07
Tc-94m         8.E-01    5.E-04         1.E-07    1.E-07
Tc-94          8.E-01    2.E-04         4.E-08    6.E-08
Tc-96m 3/      8.E-01    4.E-03         7.E-07    6.E-07
Tc-96          8.E-01    5.E-05         7.E-09    5.E-09
Tc-97m         8.E-01    1.E-04         2.E-08    3.E-09
Tc-97          8.E-01    9.E-04         1.E-07    1.E-08
Tc-98          8.E-01    3.E-05         4.E-09    7.E-10
Tc-99m 3/      8.E-01    2.E-03         4.E-07    6.E-07
Tc-99          8.E-01    1.E-04         1.E-08    2.E-09
Tc-101 3/      8.E-01    4.E-03         8.E-07    9.E-07
Tc-104         8.E-01    8.E-04         2.E-07    2.E-07

Ru-94          5.E-02    4.E-04         1.E-07    1.E-07    1.E-07
Ru-97          5.E-02    2.E-04         4.E-08    3.E-08    3.E-08
Ru-103         5.E-02    5.E-05         4.E-09    2.E-09    2.E-09
Ru-105 3/      5.E-02    1.E-04         3.E-08    3.E-08    3.E-08
Ru-106         5.E-02    6.E-06         2.E-10    1.E-10    3.E-11

Rh-99m         5.E-02    5.E-04         1.E-07    2.E-07    2.E-07
Rh-99          5.E-02    7.E-05         7.E-09    5.E-09    5.E-09
Rh-100         5.E-02    4.E-05         1.E-08    9.E-09    9.E-09
Rh-101m        5.E-02    2.E-04         3.E-08    2.E-08    2.E-08
Rh-101         5.E-02    6.E-05         1.E-09    2.E-09    4.E-10
Rh-102m        5.E-02    4.E-05         1.E-09    9.E-10    3.E-10
Rh-102         5.E-02    2.E-05         2.E-10    4.E-10    1.E-10
Rh-103m        5.E-02    1.E-02         3.E-06    3.E-06    3.E-06
Rh-105         5.E-02    1.E-04         3.E-08    1.E-08    1.E-08
Rh-106m        5.E-02    2.E-04         6.E-08    9.E-08    8.E-08
Rh-107         5.E-02    3.E-03         6.E-07    6.E-07    6.E-07

Pd-100         5.E-03    4.E-05         3.E-09    3.E-09    3.E-09
Pd-101         5.E-03    4.E-04         7.E-08    8.E-08    7.E-08
Pd-103         5.E-03    2.E-04         1.E-08    1.E-08    8.E-09
Pd-107         5.E-03    1.E-03         5.E-08    2.E-08    9.E-10
Pd-109         5.E-03    6.E-05         1.E-08    1.E-08    1.E-08

Ag-102         5.E-02    2.E-03         4.E-07    5.E-07    5.E-07
Ag-103         5.E-02    1.E-03         2.E-07    3.E-07    3.E-07
Ag-104m        5.E-02    9.E-04         2.E-07    3.E-07    3.E-07
Ag-104         5.E-02    6.E-04         2.E-07    4.E-07    4.E-07
Ag-105         5.E-02    7.E-05         3.E-09    4.E-09    4.E-09
Ag-106m        5.E-02    2.E-05         2.E-09    2.E-09    2.E-09

                        Figure III-1 (contd)

                         Ingested         Inhaled Air DCG (uCi/mL)
                f 1/     Water DCG      -----------------------------
Radionuclide   Value     (uCi/mL)           D         W        Y
------------   -----     ---------      --------- --------- ---------
Ag-106         5.E-02    2.E-03         4.E-07    5.E-07    5.E-07
Ag-108m        5.E-02    2.E-05         4.E-10    6.E-10    6.E-11
Ag-110m        5.E-02    1.E-05         3.E-10    4.E-10    2.E-10
Ag-111         5.E-02    3.E-05         4.E-09    2.E-09    2.E-09
Ag-112         5.E-02    9.E-05         2.E-08    2.E-08    2.E-08
Ag-115         5.E-02    9.E-04         2.E-07    2.E-07    2.E-07

Cd-104         5.E-02    6.E-04         2.E-07    3.E-07    3.E-07
Cd-107         5.E-02    6.E-04         1.E-07    1.E-07    1.E-07
Cd-109         5.E-02    1.E-05         1.E-10    3.E-10    3.E-10
Cd-113m        5.E-02    9.E-07         8.E-12    3.E-11    3.E-11
Cd-113         5.E.02    8.E-07         8.E-12    3.E-11    3.E-11
Cd-115m        5.E-02    9.E-06         2.E-10    3.E-10    3.E-10
Cd-115         5.E-02    3.E-05         3.E-09    3.E-09    3.E-09
Cd-117m 3/     5.E-02    1.E-04         3.E-08    4.E-08    3.E-08
Cd-117 3/      5.E-02    1.E-04         3.E-08    4.E-08    3.E-08

In-109         2.E-02    5.E-04         1.E-07    2.E-07
In-110 (69min) 2.E-02    4.E-04         1.E-07    1.E-07
In-110 (5 h)   2.E-02    1.E-04         4.E-08    5.E-08
In-111         2.E-02    1.E-04         2.E-08    2.E-08
In-112         2.E-02    6.E-03         1.E-06    2.E-06
In-113m 3/     2.E-02    1.E-03         3.E-07    5.E-07
In-114m        2.E-02    9.E-06         2.E-10    2.E-10
In-115m        2.E-02    4.E-04         1.E-07    1.E-07
In-115         2.E-02    1.E-06         3.E-12    1.E-11
In-116m 3/     2.E-02    1.E-04         2.E-07    3.E-07
In-117m        2.E-02    3.E-04         8.E-08    1.E-07
In-117 3/      2.E-02    2.E-03         4.E-07    5.E-07
In-119m        2.E-02    1.E-03         3.E-07    3.E-07

Sn-110         2.E-02    9.E-05         3.E-08    3.E-08
Sn-111         2.E-02    2.E-03         5.E-07    6.E-07
Sn-113         2.E-02    5.E-05         3.E-09    1.E-09
Sn-117m        2.E-02    5.E-05         5.E-09    3.E-09
Sn-119m        2.E-02    1.E-04         6.E-09    2.E-09
Sn-121m        2.E-02    1.E-04         2.E-09    1.E-09
Sn-121         2.E-02    2.E-04         4.E-08    3.E-08
Sn-123m        2.E-02    1.E-03         3.E-07    3.E-07
Sn-123         2.E-02    2.E-05         1.E-09    4.E-10
$n-125         2.E-02    1.E-05         2.E-09    8.E-10
Sn-126         2.E-02    8.E-06         1.E-10    2.E-10
Sn-127         2.E-02    2.E-04         5.E-08    4.E-08

                        Figure III-1 (contd)

                         Ingested         Inhaled Air DCG (uCi/mL)
                f 1/     Water DCG      -----------------------------
Radionuclide   Value     (uCi/mL)           D         W        Y
------------   -----     ---------      --------- --------- ---------
Sn-128         2.E-02    3.E-04         6.E-08     9.E-08

Sb-115         1.E-01    2.E-03         6.E-07
               1.E-02    2.E-03                   7.E-07
Sb-116m        1.E-01    6.E-04         2.E-07
               1.E-02    6.E-04                   3.E-07
Sb-116         1.E-01    2.E-03         7.E-07
               1.E-02    2.E-03                   8.E-07
Sb-117 3/      1.E-01    2.E-03         5.E-07
               1.E-02    2.E-03                   7.E-07
Sb-118m        1.E-01    2.E-04         5.E-08
               1.E-02    1.E-04                   5.E-08
Sb-119         1.E-01    4.E-04         1.E-07
               1.E-02    4.E-04                   6.E-08
Sb-120 (16min) 1.E-01    5.E-03         1.E-06
               1.E-02    5.E-03                   1.E-06
Sb-120 (6 d)   1.E-01    3.E-05         5.E-09
               1.E-02    3.E-05                   3.E-09
Sb-122         1.E-01    2.E-05         5.E-09
               1.E-02    2.E-05                   3.E-09
Sb-124m        1.E-01    7.E-03         2.E-06
               1.E-02    7.E-03                   1.E-06
Sb-124         1.E-01    2.E-05         2.E-09
               1.E-02    1.E-05                   6.E-10
Sb-125         1.E-01    6.E-05         6.E-09
               1.E-02    5.E-05                   1.E-09
Sb-126m 3/     1.E-01    2.E-03         4.E-07
               1.E-02    2.E-03                   5.E-07
Sb-126         1.E-01    2.E-05         3.E-09
               1.E-02    1.E-05                   1.E-09
Sb-127         1.E-01    2.E-05         5.E-09
               1.E-02    2.E-05                   2.E-09
Sb-128 (9 h)   1.E-01    3.E-05         1.E-08
               1.E-02    3.E-05                   8.E-09
Sb-128 (10min) 1.E-01    3.E-03         9.E-07
               1.E-02    3.E-03                   1.E-06
Sb-129/3       1.E-01    5.E-05         2.E-08
               1.E-02    8.E-05                   2.E-08
Sb-130         1.E-01    5.E-04         1.E-07
               1.E-02    5.E-04                   2.E-07
Sb-131         1.E-01    5.E-04         9.E-08
               1.E-02    5.E-04                   1.E-07

                        Figure III-1 (contd)

                         Ingested         Inhaled Air DCG (uCi/mL)
                f 1/     Water DCG      -----------------------------
Radionuclide   Value     (uCi/mL)           D         W        Y
------------   -----     ---------      --------- --------- ---------
Te-116         2.E-01    2.E-04         5.E-08    7.E-08
Te-121m        2.E-01    2.E-05         9.E-10    1.E-09
Te-121         2.E-01    9.E-05         1.E-08    7.E-09
Te-123m        2.E-01    3.E-05         1.E-09    1.E-09
Te-123         2.E-01    3.E-05         1.E-09    3.E-09
Te-125m        2.E-01    4.E-05         2.E-09    2.E-09
Te-127m        2.E-01    2.E-05         1.E-09    6.E-10
Te-127         2.E-01    2.E-04         5.E-08    4.E-08
Te-129m        2.E-01    1.E-05         1.E-09    6.E-10
Te-129         2.E-01    7.E-04         2.E-07    2.E-07
Te-131m        2.E-01    9.E-06         3.E-09    2.E-09
Te-131         2.E-01    7.E-04         1.E-07    1.E-07
Te-132         2.E-01    2.E-05         2.E-09    2.E-09
Te-133m 3/     2.E-01    2.E-04         3.E-08    3.E-08
Te-133 3/      2.E-01    9.E-04         1.E-07    1.E-07
Te-134 3/      2.E-01    7.E-04         1.E-07    1.E-07

I-120m         1.E+00    4.E-04         5.E-08
I-120          1.E+00    2.E-04         3.E-08
I-121          1.E+00    8.E-04         1.E-07
I-123          1.E+00    3.E-04         4.E-08
I-124          1.E+00    4.E-06         6.E-10
I-125          1.E+00    4.E-06         5.E-10
I-126          1.E+00    2.E-06         3.E-10
I-128 3/       1.E+00    2.E-03         3.E-07
I-129          1.E+00    5.E-07         7.E-11
I-130          1.E+00    3.E-05         5.E-09
I-131          1.E+00    3.E-06         4.E-10
I-132m         1.E+00    3.E-04         5.E-08
I-132 3/       1.E+00    2.E-04         4.E-08
I-133          1.E+00    1.E-05         2.E-09
I-134 3/       1.E+00    7.E-04         1.E-07
I-135 3/       1.E+00    7.E-05         1.E-08

Cs-125         1.E+00    2.E-03         3.E-07
Cs-127         1.E+00    2.E-03         2.E-07
Cs-129 3/      1.E+00    6.E-04         8.E-08
Cs-130         1.E+00    3.E-03         4.E-07
Cs-131         1.E+00    6.E-04         7.E-08
Cs-132         1.E+00    7.E-05         1.E-08
Cs-134m        1.E+00    3.E-03         3.E-07
Cs-134         1.E+00    2.E-06         2.E-10
Cs-135m        1.E+00    3.E-03         5.E-07

                        Figure III-1 (contd)

                         Ingested         Inhaled Air DCG (uCi/mL)
                f 1/     Water DCG      -----------------------------
Radionuclide   Value     (uCi/mL)           D         W        Y
------------   -----     ---------      --------- --------- ---------
Cs-135         1.E+00    2.E-05         3.E-09
Cs-136         1.E+00    1.E-05         2.E-09
Cs-137         1.E+00    3.E-06         4.E-10
Cs-138 3/      1.E+00    9.E-04         1.E-07

Ba-126         1.E-01    2.E-04         4.E-08
Ba-128         1.E-01    1.E-05         4.E-09
Ba-131m        1.E-01    1.E-02         3.E-06
Ba-131         1.E-01    8.E-05         2.E-08
Ba-133m        1.E-01    7.E-05         2.E-08
Ba-133         1.E-01    4.E-05         2.E-09
Ba-135m        1.E-01    9.E-05         3.E-05
Ba-139         1.E-01    3.E-04         7.E-08
Ba-140         1.E-01    2.E-05         3.E-09
Ba-141 3/      1.E-01    7.E-04         2.E-07
Ba-142 3/      1.E-01    1.E-03         3.E-07

La-131         1.E-03    1.E-03         3.E-07    4.E-07
La-132         1.E-03    9.E-05         2.E-05    3.E-08
La-135         1.E-03    1.E-03         3.E-07    2.E-07
La-137         1.E-03    3.E-04         2.E-10    6.E-10
La-138         1.E-03    2.E-05         8.E-12    3.E-11
La-140         1.E-03    2.E-05         3.E-09    3.E-09
La-141         1.E-03    1.E-04         2.E-08    3.E-08
La-142         1.E-03    2.E-04         5.E-08    8.E-08
La-143         1.E-03    1.E-03         2.E-07    2.E-07

Ce-134         3.E-04    2.E-05                   2.E-09    2.E-09
Ce-135         3.E-04    4.E-05                   9.E-09    8.E-09
Ce-137m        3.E-04    7.E-05                   1.E-08    9.E-09
Ce-137         3.E-04    1.E-03                   3.E-07    3.E-07
Ce-139         3.E-04    1.E-04                   2.E-09    2.E-09
Ce-141         3.E-04    5.3-05                   2.E-09    1.E-09
Ce-143         3.E-04    3.E-05                   4.E-09    4.E-09
Ce-144         3.E-04    7.E-06                   6.E-11    3.E-11

Pr-136         3.E-04    2.E-03                   6.E-07    5.E-07
Pr-137         3.E-04    1.E-03                   4.E-07    3.E-07
Pr-138m        3.E-04    3.E-04                   1.E-07    1.E-07
Pr-139         3.E-04    1.E-03                   3.E-07    3.E-07
Pr-142m        3.E-04    2.E-03                   4.E-07    3.E-07
Pr-142         3.E-04    3.E-05                   5.E-09    4.E-09
Pr-143         3.E-04    3.E-05                   2.E-09    2.E-09

                        Figure III-1 (contd)

                         Ingested         Inhaled Air DCG (uCi/mL)
                f 1/     Water DCG      -----------------------------
Radionuclide   Value     (uCi/mL)           D         W        Y
------------   -----     ---------      --------- --------- ---------
Pr-144         3.E-04    1.E-03                   3.E-07    3.E-07
Pr-145         3.E.04    9.E-05                   2.E-08    2.E-08
Pr-147         3.E-04    2.E-03                   5.E-07    4.E-07

Nd-136         3.E-04    4.E-04                   1.E-07    1.E-07
Nd-138         3.E-04    5.E-05                   2.E-08    1.E-08
Nd-139m        3.E-04    1.E-04                   4.E-08    3.E-08
Nd-139         3.E-04    2.E-03                   8.E-07    7.E-07
Nd-141         3.E-04    4.E-03                   2.E-06    1.E-06
Nd-147         3.E-04    4.E-05                   2.E-09    2.E-09
Nd-149 3/      3.E-04    3.E-04                   6.E-08    6.E-08
Nd-151         3.E-04    2.E-03                   5.E-07    4.E-07

Pm-141         3.E-04    2.E-03                   4.E-07    4.E-07
Pm-143         3.E-04    1.E-04                   1.E-09    2.E-09
Pm-144         3.E-04    3.E-05                   3.E-10    3.E-10
Pm-145         3.E-04    3.E-04                   5.E-10    4.E-10
Pm-146         3.E-04    4.E-05                   1.E-10    1.E-10
Pm-147         3.E-04    1.E-04                   5.E-10    3.E-10
Pm-148m        3.E-04    2.E-05                   7.E-10    7.E-10
Pm-148         3.E-04    1.E-05                   1.E-09    1.E-09
Pm-149         3.E-04    4.E-05                   4.E-08    4.E-09
Pm-150         3.E-04    1.E-04                   4.E-08    4.E-08
Pm-151         3.E-04    5.E-05                   8.E-09    7.E-09

Sm-141m        3.E-04    8.E-04                   2.E-07
Sm-141         3.E-04    2.E-03                   4.E-07
Sm-142         3.E-04    2.E-04                   6.E-08
Sm-145         3.E-04    2.E-04                   1.E-09
Sm-146         3.E-04    7.E-07                   2.E-13
Sm-147         3.E-04    8.E-07                   2.E-13
Sm-151         3.E-04    4.E-04                   4.E-10
Sm-153         3.E-04    5.E-05                   7.E-09
Sm-155         3.E-04    2.E-03                   5.E-07
Sm-156         3.E-04    1.E-04                   2.E-08

Eu-145         1.E-03    4.E-05                   5.E.09
Eu-146         1.E-03    3.E-05                   3.E-09
Eu-147         1.E-03    8.E-05                   4.E-09
Eu-148         1.E-03    3.E-05                   8.E-10
Eu-149         1.E-03    3.E-04                   7.E-09
Eu-150 (12 h)  1.E-03    9.E-05                   2.E-08
Eu-150 (34 yr) 1.E-03    2.E-05                   4.E-11

                        Figure III-1 (contd)

                         Ingested         Inhaled Air DCG (uCi/mL)
                f 1/     Water DCG      -----------------------------
Radionuclide   Value     (uCi/mL)           D         W        Y
------------   -----     ---------      --------- --------- ---------
Eu-152m        1.E-03    7.E-05                   2.E-08
Eu-152         1.E-03    2.E-05                   5.E-11
Eu-154         1.E-03    2.E-05                   5.E-11
Eu-155         1.E-03    1.E-04                   3.E-10
Eu-156         1.E-03    2.E-05                   1.E-09
Eu-157         1.E-03    6.E-05                   1.E-08
Eu-158         1.E-03    5.E-04                   1.E-07

Gd-145         3.E-04    1.E-03         4.E-07    4.E-07
Gd-146         3.E-04    4.E-05         3.E-10    7.E-10
Gd-147         3.E-04    5.E-05         1.E-08    8.E-09
Gd-148         3.E-04    7.E-07         4.E-14    1.E-13
Gd-149         3.E-04    8.E-05         5.E-09    6.E-09
Gd-151         3.E-04    2.E-04         1.E-09    3.E-09
Gd-152         3.E-04    9.E-07         5.E-14    2.E-13
Gd-153         3.E-04    1.E-04         6.E-10    1.E-09
Gd-159         3.E-04    7.E-05         2.E-08    1.E-08

Tb-147         3.E-04    2.E-04                   7.E-08
Tb-149         3.E-04    1.E-04                   2.E-09
Tb-150         3.E-04    1.E-04                   5.E-08
Tb-151         3.E-04    1.E-04                   2.E-08
Tb-153         3.E-04    1.E-04                   2.E-08
Tb-154         3.E-04    5.E-05                   1.E-08
Tb-155         3.E-04    2.E-04                   2.E-08
Tb-156m (24 h) 3.E-04    2.E-04                   2.E-08
Tb-156m (5 h)  3.E-04    4.E-04                   6.E-08
Tb-156         3.E-04    3.E-05                   3.E-09
Tb-157         3.E-04    1.E-03                   1.E-09
Tb-158         3.E-04    3.E-05                   5.E-11
Tb-160         3.E-04    2.E-05                   5.E-10
Tb-161         3.E-04    5.E-05                   4.E-09

Dy-155         3.E-04    2.E-04                   6.E-08
Dy-157 3/      3.E-04    5.E-04                   2.E-07
Dy-159         3.E-04    3.E-04                   6.E-09
Dy-165         3.E-04    4.E-04                   1.E-07
Dy-166         3.E-04    2.E-05                   2.E-09

Ho-155         3.E-04    1.E-03                   4.E-07
Ho-157         3.E-04    7.E-03                   3.E-06
Ho-159         3.E-04    6.E-03                   2.E-06
Ho-161         3.E-04    3.E-03                   1.E-06

                        Figure III-1 (contd)

                         Ingested         Inhaled Air DCG (uCi/mL)
                f 1/     Water DCG      -----------------------------
Radionuclide   Value     (uCi/mL)           D         W        Y
------------   -----     ---------      --------- --------- ---------
Ho-162m        3.E-04    2.E-03                   6.E-07
Ho-162         3.E-04    2.E-02                   6.E-06
Ho-164m        3.E-04    3.E-03                   7.E-07
Ho-164         3.E-04    6.E-03                   1.E-06
Ho-166m        3.E-04    2.E-05                   2.E-11
Ho-166         3.E-04    2.E-05                   4.E-09
Ho-167         3.E-04    4.E-04                   1.E-07

Er-161         3.E-04    4.E-04                   2.E-07
Er-165         3.E-04    2.E-03                   4.E-07
Er-169         3.E-04    1.E-04                   6.E-09
Er-171         3.E-04    1.E-04                   2.E-08
Er-172         3.E-04    4.E-05                   3.E-09

Tm-162         3.E-04    2.E-03                   7.E-07
Tm-166         3.E-04    1.E-04                   3.E-08
Tm-167         3.E-04    7.E-05                   5.E-09
Tm-170         3.E-04    3.E-05                   5.E-10
Tm-171         3.E-04    4.E-04                   1.E-09
Tm-172         3.E-04    2.E-05                   3.E-09
Tm-173         3.E-04    1.E-04                   3.E-08
Tm-175         3.E-04    3.E-03                   6.E-07

Yb-161         3.E-04    2.E-03                   7.E-07    7.E-07
Yb-166         3.E-04    4.E-05                   5.E-09    4.E-09
Yb-167         3.E-04    8.E-03                   2.E-06    2.E-06
Yb-169         3.E-04    5.E-05                   2.E-09    2.E-09
Yb-175         3.E-04    9.E-05                   8.E-09    8.E-09
Yb-177         3.E-04    4.E-04                   1.E-07    1.E-07
Yb-178         3.E-04    4.E-04                   1.E-07    9.E-08

Lu-169         3.E-04    7.E-05                   1.E-08    1.E-08
Lu-170         3.E-04    3.E-05                   5.E-09    5.E-09
Lu-171         3.E-04    5.E-05                   4.E-09    5.E-09
Lu-172         3.E-04    3.E-05                   3.E-09    3.E-09
Lu-173         3.E-04    1.E-04                   1.E-09    6.E-10
Lu-174m        3.E-04    8.E-05                   8.E-10    5.E-10
Lu-174         3.E-04    1.E-04                   6.E-10    4.E-10
Lu-176m        3.E-04    2.E-04                   6.E-08    5.E-08
Lu-176         3.E-04    2.E-05                   3.E-11    2.E-11
Lu-177m        3.E-04    2.E-05                   3.E-10    2.E-10
Lu-177         3.E-04    7.E-05                   5.E-09    5.E-09
Lu-178m        3.E-04    2.E-03                   4.E-07    4.E-07

                        Figure III-1 (contd)

                         Ingested         Inhaled Air DCG (uCi/mL)
                f 1/     Water DCG      -----------------------------
Radionuclide   Value     (uCi/mL)           D         W        Y
------------   -----     ---------      --------- --------- ---------
Lu-178         3.E-04    1.E-03                   3.E-07    3.E-07
Lu-179         3.E-04    2.E-04                   4.E-08    4.E-08

Hf-170         2.E-03    7.E-05         1.E-08    1.E-08
Hf-172         2.E-03    3.E-05         4.E-11    1.E-10
Hf-I73         2.E-03    1.E-04         3.E-08    3.E-08
Hf-175         2.E-03    8.E-05         2.E-09    3.E-09
Hf-177m        2.E-03    5.E-04         1.E-07    2.E-07
Hf-178m        2.E-03    7.E-06         6.E-12    2.E-11
Hf-179m        2.E-03    3.E-05         1.E-09    1.E-09
Hf-180m        2.E-03    2.E-04         5.E-08    6.E-08
Hf-181         2.E-03    3.E-05         9.E-10    1.E-09
Hf-182m        2.E-03    1.E-03         2.E-07    3.E-07
Hf-l82         2.E-03    1.E-05         4.E-12    2.E-11
Hf-183         2.E-03    6.E-04         1.E-07    1.E-07
Hf-184         2.E-03    7.E-05         2.E-08    2.E-08

Ta-172         1.E-03    1.E-03                   3.E-07    2.E-07
Ta-173         1.E-03    2.E-04                   5.E-08    4.E-08
Ta-174         1.E-03    7.E-04                   2.E-07    2.E-07
Ta-175         1.E-03    2.E-04                   4.E-08    3.E-08
Ta-176         1.E-03    1.E-04                   3.E-08    3.E-08
Ta-177         1.E-03    3.E-04                   5.E-08    4.E-08
Ta-178         1.E-03    5.E-04                   2.E-07    2.E-07
Ta-179         1.E-03    6.E-04                   1.E-08    2.E-09
Ta-180m        1.E-03    6.E-04                   2.E-07    1.E-07
Ta-180         1.E-03    4.E-05                   1.E-09    6.E-11
Ta-182m        1.E-03    6.E-03                   1.E-06    1.E-06
Ta-182         1.E-03    2.E-05                   7.E-10    3.E-10
Ta-183         1.E-03    3.E-05                   3.E-09    2.E-09
Ta-184         1.E-03    5.E-05                   1.E-08    1.E-08
Ta-185         1.E-03    7.E-04                   2.E-07    2.E-07
Ta-186         1.E-03    2.E-03                   5.E-07    5.E-07

W-176          1.E-02    3.E-04
               3.E-01    4.E-04         1.E-07
W-177          1.E-02    6.E-04
               3.E-01    7.E-04         2.E-07
W-178          1.E-02    1.E-04
               3.E-01    2.E-04         5.E-08
W-179          1.E-02    2.E-02
               3.E-01    2.E-02         4.E-06
W-181          1.E-02    4.E-04

                        Figure III-1 (contd)

                         Ingested         Inhaled Air DCG (uCi/mL)
                f 1/     Water DCG      -----------------------------
Radionuclide   Value     (uCi/mL)           D         W        Y
------------   -----     ---------      --------- --------- ---------
W-181          3.E-01    5.E-04         8.E-08
W-185          1.E-02    7.E-05
               3.E-01    1.E-04         2.E-08
W-187          1.E-02    5.E-02
               3.E-01    7.E-05         2.E-08
W-188          1.E-02    2.E-05
               3.E-01    2.E-05         3.E-09

Re-177         8.E-01    3.E-03         6.E-07    8.E-07
Re-178         8.E-01    3.E-03         6.E-07    7.E-07
Re-181         8.E-01    1.E-04         2.E-08    2.E-08
Re-182 (64 h)  8.E-01    4.E-05         6.E-09    5.E-09
Re-182 (12 h)  8.E-01    2.E-04         3.E-08    4.E-08
       3/
Re-184m        8.E-01    6.E-05         7.E-09    1.E-09
Re-184         8.E-01    6.E-05         8.E-09    3.E-09
Re-186m        8.E-01    4.E-05         5.E-09    4.E-10
Re-186         8.E-01    5.E-05         7.E-09    4.E-09
Re-187         8.E-01    2.E-02         2.E-06    2.E-07
Re-188m        8.E-01    2.E-03         3.E-07    3.E-07
Re-188         8.E-01    5.E-05         7.E-09    6.E-09
Re-189         8.E-01    9.E-05         1.E-08    1.E-08

Os-180         1.E-02    3.E-03         9.E-07    1.E-06    1.E-06
Os-181         1.E-02    4.E-04         1.E-07    1.E-07    1.E-07
Os-182         1.E-02    6.E-05         1.E-08    1.E-08    9.E-09
Os-185         1.E-02    7.E-05         1.E-09    2.E-09    2.E-09
Os-189m        1.E-02    2.E-03         2.E-07    5.E-07    4.E-07
Os-191m        1.E-02    4.f-04         7.E-08    5.E-08    4.E-08
Os-191         1.E-02    7.E-05         5.E-09    4.E-09    3.E-09
Os-193         1.E-02    4.E-05         1.E-08    7.E-09    6.E-09
Os-194         1.E-02    2.E-05         1.E-10    1.E-10    2.E-11

Ir-182         1.E-02    1.E-03         3.E-07    4.E-07    3.E-07
Ir-184         1.E-02    2.E-04         6.E-08    7.E-08    6.E-08
Ir-185         1.E-02    1.E-04         3.E-08    3.E-08    2.E-08
Ir-186         1.E-02    6.E-05         2.E-08    1.E-08    1.E-08
Ir-187         1.E-02    3.E-04         7.R-08    7.E-08    6.E-08
Ir-188         1.E-02    5.E-05         1.E-08    8.E-09    8.E-09
Ir-189         1.E-02    1.E-04         1.E-08    9.E-09    9.E-09
Ir-190m 3/     1.E-02    5.E-03         5.E-07    5.E-07    5.E-07
Ir-190         1.E-02    3.E-05         2.E-09    2.E-09    2.E-09
Ir-192m        1.E-02    9.E-05         2.E-10    2.E-10    4.E-11
Ir-192         1.E-02    3.E-05         6.E-10    9.E-10    5.E-10

                        Figure III-1 (contd)

                         Ingested         Inhaled Air DCG (uCi/mL)
                f 1/     Water DCG      -----------------------------
Radionuclide   Value     (uCi/mL)           D         W        Y
------------   -----     ---------      --------- --------- ---------
Ir-194m        1.E-02    2.E-05         2.E-10    4.E-10    2.E-10
Ir-194         1.E-02    3.E-05         7.E-09    5.E-09    4.E-09
Ir-195m        1.E-02    2.E-04         6.f-08    7.E-08    5.E-05
Ir-195         1.E-02    4.E-04         1.E-07    1.E-07    1.E-07

Pt-186         1.E-02    4.E-04         9.E-08
Pt-188         1.E-02    4.E-05         4.E-09
Pt-189         1.E-02    3.E-04         7.E-08
Pt-191         1.E-02    1.E-04         2.E-08
Pt-193m        1.E-02    8.E-05         1.E-08
Pt-193         1.E-02    1.E-03         6.E-08
Pt-195m        1.E-02    6.E-05         1.E-08
Pt-197m        1.E-02    4.E-04         1.E-07
Pt-197         1.E-02    9.E-05         2.E-08
Pt-199         1.E-02    1.E-03         3.E-07
Pt-200         1.E-02    3.E-05         8.E-09

Au-193         1.E-01    2.E-04         3.E-08    4.E-08    4.E-08
Au-194         1.E-01    7.E-05         9.E-09    3.E-09    1.E-08
Au-195         1.E-01    1.E-04         1.E-08    3.E-09    1.E-09
Au-198m        1.E-01    2.E-05         3.E-09    2.E-09    2.E-09
Au-198         1.E-01    6.E-05         4.E-09    6.E-09    7.E-09
Au-199         1.E-01    8.E-05         8.E-09    8.E-09    8.E-09
Au-200m        1.E-01    3.E-05         4.E-09    5.E-09    6.E-09
Au-200         1.E-01    7.E-04         9.E-08    1.E-07    2.E-07
Au-201         1.E-01    2.E-03         3.E-07    5.E-07    5.E-07

Hg-193m (Org)  1.E+00    3.E-04         3.E-08
               4.E-01    1.E-04
Hg-193m        2.E-02    9.E-05         2.E-08    2.E-08
Hg-193m (Vapor)                         2.E-08
Hg-193 (Org)   1.E+00    1.E-03         2.E-07
               4.E-01    5.E-04
Hg-193         2.E-02    4.E-04         1.E-07    1.E-07
Hg-193 (Vapor)                          7.E-08
Hg-194 (Org)   1.E+00    5.E-07         7.E-11
               4.E-01    1.E-06
Hg-194         2.E-02    2.E-05         1.E-10    3.E-10
Hg-194 (Vapor)                          7.E-11
Hg-195m (Org)  1.E+00    1.E-04         1.E-08
               4.E-01    8.E-05
Hg-195m        2.E-02    6.E-05         1.E-08    9.E-09
Hg-195m (Vapor)                         9.E-09

                        Figure III-1 (contd)

                         Ingested         Inhaled Air DCG (uCi/mL)
                f 1/     Water DCG      -----------------------------
Radionuclide   Value     (uCi/mL)           D         W        Y
------------   -----     ---------      --------- --------- ---------
Hg-195 (Org)   1.E+00    1.E-03         1.E-07
               4.E-01    5.E-04
Hg-195         2.E-02    4.E-04         8.E-08    8.E-08
Hg-195 (Vapor)                          7.E-08
Hg-197m (Org)  1.E+00    2.E-04         2.E-08
               4.E-01    1.E-04
Hg-197m        2.E-02    8.E-05         2.E-08    1.E-08
Hg-197m (Vapor)                         1.f-08
kg-197 (Org)   1.E+00    3.E-04         3.E-08
               4.E-01    2.E-04
Hg-197         2.E-02    1.E-04         3.E-08    2.E-08
Hg-197 (Vapor)                          2.E-07
Hg-199m (Org)  1.E+00    3.E-03         4.E-07
               4.E-01    2.E-03
Hg-199m        2.E-02    2.E-03         4.E-07    4.E-07
Hg-199m (Vapor)                         2.E-07
Hg-203 (Org)   1.E+00    1.E-05         2.E-09
               4.E-01    2.E-05
Hg-203         2.E-02    7.E-05         3.E-09    3.E-09
Hg-203 (Vapor)                          2.E-09

Tl-194m        1.E+00    2.E-03         4.E-07
Tl-194         1.E+00    7.E-03         1.E-06
Tl-195         1.E+00    2.E-03         3.E-07
Tl-197         1.E+00    2.E-03         3.E-07
Tl-198m        1.E+00    8.E-04         1.E-07
Tl-198         1.E+00    5.E-04         7.E-08
Tl-199         1.E+00    2.E-03         2.E-07
Tl-200 3/      1.E+00    2.E-04         3.E-08
Tl-201         1.E+00    5.E-04         5.E-08
Tl-202         1.E+00    9.E-05         1.E-08
Tl-204         1.E+00    4.E-05         5.E-09

Pb-195m        2.E-01    2.E-03         5.E-07
Pb-198         2.E-01    9.E-04         2.E-07
Pb-199         2.E-01    6.E-04         2.E-07
Pb-200         2.E-01    9.E-05         1.E-08
Pb-201         2.E-01    2.E-04         5.E-08
Pb-202m        2.E-01    2.E-04         7.E-08
Pb-202         2.E-01    4.E-06         1.E-10
Pb-203         2.E-01    1.E-04         2.E-08
Pb-205         2.E-01    9.E-05         3.E-09
Pb-209         2.E-01    7.E-04         1.E-07

                        Figure III-1 (contd)

                         Ingested         Inhaled Air DCG (uCi/mL)
                f 1/     Water DCG      -----------------------------
Radionuclide   Value     (uCi/mL)           D         W        Y
------------   -----     ---------      --------- --------- ---------
Pb-210         2.E-01    3.E-08         9.E-13
Pb-211         2.E-01    3.E-04         1.E-09
Pb-212         2.E-01    3.E-06         8.E-11
Pb-214         2.E-01    2.E-04         2.E-09

Bi-200         5.E-02    8.E-04         2.E-07    2.E-07
Bi-201         5.E-02    3.E-04         7.E-08    9.E-08
Bi-202         5.E-02    4.E-04         1.E-07    2.E-07
Bi-203         5.E-02    7.E-05         2.E-08    1.E-08
Bi-205         5.E-02    4.E-05         6.E-09    3.E-09
Bi-206         5.E-02    2.E-05         3.E-09    2.E-09
Bi-207         5.E-02    3.E-05         4.E-09    8.E-10
Bi-210m        5.E-02    2.E-06         1.E-11    2.E-12
Bi-210         5.E-02    2.E-05         9.E-10    6.E-11
Bi-211         5.E-02    1.E-04         6.E-10    7.E-10
Bi-213         5.E-02    2.E-04         7.E-10    8.E-10
Bi-214         5.E-02    6.E-04         2.E-09    2.E-09

Po-203         1.E-01    7.E-04         2.E-07    2.E-07
Po-205         1.E-01    6.E-04         9.E-08    2.E-07
Po-207         1.E-01    2.E-04         6.E-08    7.E-08
Po-210         1.E-01    8.E-08         1.E-12    1.E-12

At-207         1.E+00    2.E-04         6.E-09    5.E-09
At-211         1.E+00    3.E-06         2.E-10    1.E-10

Rn-210                     4/             4/        4/        4/
Rn-211                     5/             5/        5/        5/

Fr-222         1.E+00    6.E-05         1.E-09
Fr-223         1.E+00    2.E-05         2.E-09

Ra-223         2.E-01    3.E-07                   2.E-12
Ra-224         2.E-01    4.E-07                   4.E-12
Ra-225         2.E-01    4.E-07                   2.E-12
Ra-226         2.E-01    1.E-07                   1.E-12
Ra-227         2.E-01    6.E-04                   4.E-08
Ra-228         2.E-01    1.E-07                   3.E-12

Ac-224         1.E-03    5.E-05         9.E-11    1.E-10    1.E-10
Ac-225         1.E-03    1.E-06         1.E-12    2.E-12    1.E-12
Ac-226         1.E-03    3.E-06         9.E-12    1.E-11    1.E-11
Ac-227         1.E-03    1.E-08         2.E-15    7.E-15    1.E-14
Ac-228         1.E-03    6.E-05         4.E-11    1.E-10    1.E-10

                        Figure III-1 (contd)

                         Ingested         Inhaled Air DCG (uCi/mL)
                f 1/     Water DCG      -----------------------------
Radionuclide   Value     (uCi/mL)           D         W        Y
------------   -----     ---------      --------- --------- ---------
Th-226         2.E-04    1.E-04                   4.E-10    3.E-10
Th-227         2.E-04    4.E-06                   8.E-13    7.E-13
Th-228         2.E-04    4.E-07                   5.E-14    4.E-14
Th-229         2.E-04    4.E-08                   6.E-15    7.E-15
Th-230         2.E-04    3.E-07                   4.E-14    5.E-14
Th-231         2.E-04    1.E-04                   1.E-08    2.E-08
Th-232         2.E-04    5.E-08                   7.E-15    1.E-14
Th-234         2.E-04    1.E-05                   5.E-10    4.E-10
Th-Natural     2.E-04    5.E-08                   7.E-15    1.E-14

Pa-227         1.E-03    1.E-04                   3.E-10    2.E-10
Pa-228         1.E-03    3.E-05                   5.E-11    3.E-11
Pa-230         1.E-03    2.E-05                   1.E-11    8.E-12
Pa-231         1.E-03    1.E-08                   9.E-15    1.E-14
Pa-232         1.E-03    4.E-05                   1.E-10    2.E-10
Pa-233         1.E-03    4.E-05                   2.E-09    1.E-09
Pa-234 3/      1.E-03    7.E-05                   2.E-08    2.E-08

U-230          5.E-02    2.E-07         1.E-12    8.E-13
               2.E-03    1.E-06                             6.E-13
U-231          5.E-02    1.E-04         2.E-08    1.E-08
               2.E-03    1.E-04                             1.E-08
U-232          5.E-02    1.E-07         1.E-12    9.E-33
               2.E-03    2.E-06                             2.E-04
U-233          5.E-02    5.E-07         4.E-12    2.E-12
               2.E-03    5.E-06                             9.E-14
U-234          5.E-02    5.E-07         4.E-12    2.E-12
               2.E-03    5.E-06                             9.E-14
U-235          5.E-02    6.E-07         5.E-12    2.E-12
               2.E-03    5.E-06                             1.E-13
U-236          5.E-02    5.E-07         5.E-12    2.E-12
               2.E-03    6.E-06                             1.E-13
U-237          5.E-02    5.E-05         6.E-09    4.E-09
               2.E-03    5.E-05                             4.E-09
U-238          5.E-02    6.E-07         5.E-12    2.E-12
               2.E-03    6.E-06                             1.E-13
U-239 3/       5.E-02    2.E-03         4.E-07    4.E-07
               2.E-03    2.E-03                             4.E-07
U-240          5.E-02    3.E-05         9.E-09    7.E-09
               2.E-03    3.E-05                             6.E-09
U-Natural      5.E-02    6.E-07         5.E-12    2.E-12
               2.E-03    6.E-06                             1.E-13

Np-232         1.E-03 6/ 6.E-03 7/                1.E-08 8/

                        Figure III-1 (contd)

                         Ingested         Inhaled Air DCG (uCi/mL)
                f 1/     Water DCG      -----------------------------
Radionuclide   Value     (uCi/mL)           D         W        Y
------------   -----     ---------      --------- --------- ---------
Np-233         1.E-03 6/ 2.E-02 7/                8.E-06 8/
Np-234         1.E-03 6/ 8.E-05 7/                6.E-09 8/
Np-235         1.E-03 6/ 6.E-04 7/                3.E-09 8/
Np-236 (1.E+05 1.E-03 6/ 2.E-07 7/                1.E-13 8/
        yr)
Np-236 (22 h)  1.E-03 6/ 1.E-04 7/                2.E-10 8/
Np-237         1.E-03 6/ 3.E-08 7/                2.E-14 8/
Np-238         1.E-03 6/ 4.E-05 7/                4.E-10 8/
Np-239         1.E-03 6/ 5.E-05 7/                5.E-09 8/
Np-240 3/      1.E-03 6/ 7.E-04 7/                2.E-07 8/

Pu-234         1.E-03 6/ 1.E-04 7/                5.E-10 8/
               1.E-05 6/ 2.E-04 7/                          4.E-10/8/
Pu-235         1.E-03 6/ 1.E-02 7/                7.E-06 8/
               1.E-05 6/ 2.E-02 7/                          6.E-06 8/
Pu-236         1.E-03 6/ 1.E-07 7/                8.E-14 8/
               1.E-05 6/ 5.E-06 7/                          9.E-14 8/
Pu-237         1.E-03 6/ 1.E-04 7/                8.E-09 8/
               1.E-05 6/ 3.E-04 7/                          7.E-09 8/
Pu-238         1.E-03 6/ 4.E-08 7/                3.E-14 8/
               1.E-05 6/ 3.E-06 7/                          4.E-14 8/
Pu-239         1.E-03 6/ 3.E-08 7/                2.E-14 8/
               1.E-05 6/ 2.E-06 7/                          4.E-14 8/
Pu-240         1.E-03 6/ 3.E-08 7/                2.E-14 8/
               1.E-05 6/ 2.E-06 7/                          4.E-14 8/
Pu-241         1.E-03 6/ 2.E-06 7/                1.E-12 8/
               1.E-05 6/ 1.E-04 7/                          2.E-12 8/
Pu-242         1.E-03 6/ 3.E-08 7/                2.E-14 8/
               1.E-05 6/ 2.E-06 7/                          4.E-14 8/
Pu-243         1.E-03 6/ 4.E-04 7/                8.E-14 8/
               1.E-05 6/ 4.E-04 7/                          9.E-08 8/
Pu-244         1.E-03 6/ 3.E-08 7/                2.E-14 8/
               1.E-05 6/ 2.E-06 7/                          4.E-14 8/
               1.E-03 6/ 6.E-05 7/                1.E-08 8/
Pu-245         1.E-05 6/ 6.E-05 7/                          1.E-08 8/

Am-237         1.E-03 6/ 2.E-03 7/                7.E-07 8/
Am-238         1.E-03 6/ 8.E-04 7/                1.E-08 8/
Am-239         1.E-03 6/ 1.E-04 7/                3.E-08 8/
Am-240         1.E-03 6/ 5.E-05 7/                6.E-09 8/
Am-241         1.E-03 6/ 3.E-08 7/                2.E-14 8/
Am-242m        1.E-03 6/ 3.E-08 7/                2.E-14 8/
Am-242         1.E-03 6/ 1.E-04 7/                2.E-10 8/
Am-243         1.E-03 6/ 3.E-08 7/                2.E-14 8/

                        Figure III-1 (contd)

                         Ingested         Inhaled Air DCG (uCi/mL)
                f 1/     Water DCG      -----------------------------
Radionuclide   Value     (uCi/mL)           D         W        Y
------------   -----     ---------      --------- --------- ---------
Am-244m        1.E-03 6/ 2.E-03 7/                1.E-08 8/
Am-244         1.E-03 6/ 7.E-05 7/                7.E-10 8/
Am-245         1.E-03 6/ 8.E-04 7/                2.E-07 8/
Am-246m        1.E-03 6/ 2.E-03 7/                4.E-07 8/
Am-246 3/      1.E-03 6/ 9.E-04 7/                2.E-07 8/

Cm-238         1.E-03 6/ 4.E-04 7/                3.E-09 8/
Cm-240         1.E-03 6/ 2.E-06 7/                1.E-12 8/
Cm-241         1.E-03 6/ 3.E-05 7/                7.E-11 8/
Cm-242         1.E-03 6/ 1.E-06 7/                7.E-13 8/
Cm-243         1.E-03 6/ 5.E-08 7/                3.E-14 8/
Cm-244         1.E-03 6/ 6.E-08 7/                4.E-14 8/
Cm-245         1.E-03 6/ 3.E-08 7/                2.E-14 8/
Cm-246         1.E-03 6/ 3.E-08 7/                2.E-14 8/
Cm-247         1.E-03 6/ 3.E-08 7/                2.E-14 8/
Cm-248         1.E-03 6/ 8.E-09 7/                6.E-15 8/
Cm-249         1.E-03 6/ 1.E-03 7/                5.E-08 8/

Bk-245         5.E-04    6.E-05                   3.E-09
Bk-246         5.E-04    7.E-05                   7.E-09
Bk-247         5.E-04    6.E-08                   2.E-14
Bk-249         5.E-04    2.E-05                   9.E-12
Bk-250         5.E-04    3.E-04                   2.E-09

Cf-244         1.E-03 6/ 9.E-04 7/                1.E-09 8/ 1.E-09 8/
Cf-246         1.E-03 6/ 1.E-05 7/                2.E-11 8/ 2.E-11 8/
Cf-248         1.E-03 6/ 5.E-07 7/                3.E-13 8/ 3.E-13 8/
Cf-249         1.E-03 6/ 3.E-08 7/                2.E-14 8/ 3.E-14 8/
Cf-250         1.E-03 6/ 7.E-08 7/                5.E-14 8/ 6.E-14 8/
Cf-251         1.E-03 6/ 3.E-08 7/                2.E-14 8/ 3.E-14 8/
Cf-252         1.E-03 6/ 1.E-07 7/                1.E-13 8/ 9.E-14 8/
Cf-253         1.E-03 6/ 1.E-05 7/                5.E-12 8/ 4.E-12 8/
Cf-254         5.E-04 6/ 5.E-08 7/                5.E-14 8/ 4.E-14 8/

Es-250         5.E-04    1.E-03                   3.E-09
Es-251         5.E-04    2.E-04                   3.E-09
Es-253         5.E-04    6.E-06                   4.E-12
Es-254m        5.E-04    9.E-06                   3.E-11
Es-254         5.E-04    9.E-07                   3.E-13

Fm-252         5.E-04    1.E-05                   3.E-11
Fm-253         5.E-04    4.E-05                   2.E-11
Fm-254         5.E-04    8.E-05                   2.E-10

                        Figure III-1 (contd)

                         Ingested         Inhaled Air DCG (uCi/mL)
                f 1/     Water DCG      -----------------------------
Radionuclide   Value     (uCi/mL)           D         W        Y
------------   -----     ---------      --------- --------- ---------
Fm-255         5.E-04    1.E-05                   5.E-11
Fm-257         5.E-04    2.E-06                   6.E-13

Md-257         5.E-04    3.E-04                   2.E-10
Md-258         5.E-04    2.E-06                   8.E-13

---------------
1/  A dash indicates no values given for this data category.

2/  The inhalation DCG values allow for an additional 50% absorption through
    the skin, as described in ICRP Publication No. 30: "Limits for Intakes
    of Radionuclides by Workers."  For elemental tritium, the lung dose
    equivalent is used as the basis for the DCG value shown.

3/  For the radionuclide shown, the DCG for external exposure from immersion
    in a contaminated plume (listed in figure III-2) is more restrictive.

4/  DCGs for Rn-220 are being assessed by DOE.  Until the review has been
    completed and new values issued, the value of 3.E-09 micro Ci/mL given
    in figure III-3 shall be used.

5/  DCGs for Rn-222 are being assessed by DOE.  Until the review has been
    completed and new values issued, the value of 3.E-09 micro Ci/mL given
    in Figure III-3 shall be used for Rn-222 releases from DOE facilities.
    In addition, the requirements of Chapter IV, Sections 4b, 6b, and 6d,
    shall be used when they are applicable.

6/  ICRP Publication No. 48:  "The Metabolism of Plutonium and Related
    Elements."

7/  Based on the listed f1 value.  It is assumed that individual organ
    doses, except for the gastrointestinal tract, change in proportion to f1
    for all organs, including the "Remainder."  Gastrointestinal doses are
    unchanged because very little material is absorbed in the upper portions
    of the tract.

8/  It is assumed that the effective dose equivalents are unchanged even
    though the f1 values have changed.  This is because the contribution to
    organ dose from inhalation is dependent mainly on transfer from lung to
    blood when f1 values are small.  Also the gastrointestinal tract dose
    would be unchanged because the fraction of activity passing through the
    tract is (1.0 - f1).

                        Figure III-1 (contd)

Element/       Atomic                                         Lung
Symbol         Number        Compound          f 1/       Retention Class
-------------- --------- ------------------- ------------ -----------------
Actinium/        89      Oxides, hydroxides  1.E-03       Y
 Ac                      Halides, nitrates   1.E-03       W
                         All others          1.E-03       D

Aluminum/        13      Oxides, hydroxides, 1.E-02       W
 Al                       carbides, halides,
                          nitrates, elemental
                          form
                         All Others          1.E-02       D

Americium/       95      All forms           1.E-03       W
 Am

Antimony/        51      Oxides, hydroxides, 1.E-01       D
 Sb                       halides, sulphides,
                          sulphates, nitrates
                         All others          1.E-02       W

Arsenic/         33      All Forms           5.E-01       W
 As

Astatine/        85      All (as a halide)   1.E+00       W or D; dependent
 At                                                        upon associated
                                                           element

Barium/          56      All Forms           1.E-01       D
 Ba

Berkelium/       97      All Forms           5.E-04       W
 Bk

Beryllium/        4      Oxides, halides,    5.E-03       Y
 Be                       nitrates
                         All others          5.E-03       W

Bismuth/         83      All except nitrates 5.E-02       W
 Bi                      Nitrates            5.E-02       D

Bromine/         35      Bromides            1.E+00       W or D; dependent
 Br                                                        upon associated
                                                           element

                               Figure III-2
         Alternative Absorption factors and Lung Retention Classes
                          for Specific Compounds

Element/       Atomic                                         Lung
Symbol         Number        Compound          f 1/       Retention Class
-------------- --------- ------------------- ------------ -----------------
Cadmium/         48      Oxides, hydroxides  5.E-02       Y
 Cd                      Sulphates, halides  5.E-02       W
                         All others          5.E-02       D

Calcium/         20      All Forms           3.E-01       W
 Ca

Californium/     98      Oxides, hydroxides  1.E-03       Y
 Cf                      All others          1.E-03       W

Carbon/           6      Oxides                1/         D
 C                       Organic (11 C)      1.E-02       W
                         Organic (14 C)      7.E-05       W

Cerium/          58      Oxides, hydroxides, 3.E-04       Y
 Ce                       fluorides
                         All others          3.E-04       W

Cesium/          55      All Forms           1.E+00       D
 Cs

Chlorine/        17      Chloride            1.E+00       W or D; dependent
 Cl                                                        upon associated
                                                           element

Chromium/        24      Oxides, hydroxides  1.E-01       Y
 Cr                      Halides, nitrates   1.E-01       W
                         All Others          1.E-01       D

                         Ingestion 2/
                         Trivalent           1.E-02
                         Hexavalent          1.E-01

Cobalt/          27      Oxides, hydroxides, 5.E-02       Y
 Co                       halides, nitrates
                         All others          5.E-01       W
                         Ingestion only      3.E-01

                         Figure III-2 (contd)

Element/       Atomic                                         Lung
Symbol         Number        Compound          f 1/       Retention Class
-------------- --------- ------------------- ------------ -----------------
Copper/          29      Oxides, hydroxides  5.E-01       Y
 Cu                      Sulphites, halides, 5.E-01       W
                          nitrates
                         All others          5.E-01       D

Curium/          96      All forms           1.E-03       W
 Cm

Dysprosium/      66      All forms           3.E-04       W
 Dy

Einsteinium/     99      All Forms           5.E-04       W
 Es

Erbium/          68      All forms           3.E-04       W
 Er

Europium/        63      All forms           1.E-03       W
 Eu

Fermium/        100      All forms           5.E-04       W
 Fm

Fluorine/         9      Fluoride            1.E+00       Y, W, or D;
                                                           dependent upon
                                                           associated
                                                           element

Francium/        87      All Forms           1.E+00       D
 Fr

Gadolinium/      64      Oxides, hydroxides, 3.E-04       W
 Gd                       fluorides
                         All others          3.E-04

Gallium/         31      Oxides, hydroxides, 1.E-03       W
 Ga                       carbides, halides,
                          nitrates,
                         All others          1.E-03       D

Germanium/       32      Oxides, sulphides,  1.E+00       W
 Ge                       halides
                         All others          1.E+00       D

                         Figure III-2 (contd)

Element/       Atomic                                         Lung
Symbol         Number        Compound          f 1/       Retention Class
-------------- --------- ------------------- ------------ -----------------
Gold/            79      Oxides, hydroxides  1.E-01       Y
 Au                      Halides, nitrates   1.E-01       W
                         All others          1.E-01       D

Hafnium/         72      Oxides, hydroxides, 1.E-03       W
 Hf                       halides, carbides,
                          nitrates
                         All others          1.E-03       D

Holmium/         67      All Forms           3.E-04       W
 Ho

Hydrogen/         1      Water (3H)          1.E+00
 H

Indium/          49      Oxides, hydroxides, 2.E-02       W
 In                       halides
                         All others          2.E-02       D

Iodine/          53      All forms           1.E+00       D
 I

Iridium/         77      Oxides, hydroxides  1.E-02       Y
 Ir                      Halides, nitrates,  1.E-02       W
                         metallic form
                         All others          1.E-02       D

Iron/            26      Oxides, hydroxides, 1.E-01       W
 Fe                       halides
                         All others          1.E-01       D

Lanthanum/       57      Oxides, hydroxides  1.E-03       W
 La                      All others          1.E-03       D

Lead/            81      All forms           2.E-01       D
 Pb

Lutetium/        71      Oxides, hydroxides, 3.E-04       Y
 Lu                       fluorides
                         All others          3.E-04       W

                         Figure III-2 (contd)

Element/       Atomic                                         Lung
Symbol         Number        Compound          f 1/       Retention Class
-------------- --------- ------------------- ------------ -----------------
Magnesium/       12      Oxides, hydroxides, 5.E-01       W
 Mg                       carbides, halides,
                          nitrates
                         All others          5.E-01       D

Manganese/       25      Oxides, hydroxides, 1.E-01       W
 Mn                       halides, nitrates
                         All others          1.E-01       D

Mendelevium/    101      All forms           5.E-04       W
 Md

Mercury/         80      Oxides, hydroxides, 2.E-02       W
 Hg                       halides, nitrates,
                          sulphites
                         Sulphates,          2.E-02       D
                          elemental form
                         Organic Forms       1.E+00       D
                         Vapor                            D

Molybdenum/      42      Oxides, hydroxides, 5.E-02       Y
 Mo                      MoS2
                         All others          8.E-01       D

                         Ingestion 2/
                         MoS2                5.E-02
                         All others          8.E-01

Neodymium/       60      Oxides, hydroxides, 3.E-04       Y
 Nd                       carbides, fluorides
                         All others          3.E-04       W

Neptunium/       93      All forms           1.E-03       W
 Np

Nickel/          28      Oxides, hydroxides  5.E-01       W
 Ni                      All others (vapor)               D

Niobium/         41      Oxides, hydroxides  1.E-02       Y
 Nb                      All others          1.E-02       W

                         Figure III-2 (contd)

Element/       Atomic                                         Lung
Symbol         Number        Compound          f 1/       Retention Class
-------------- --------- ------------------- ------------ -----------------
Osmium/          76      Oxides, hydroxides  1.E-02       Y
 Os                      Halides, nitrates   1.E-02       W
                         All others          1.E-02       D

Palladium/       46      Oxides, hydroxides  5.E-03       Y
 Pd                      Nitrates            5.E-03       W
                         All others          5.E-03       D

Phosphorus/      15      Phosphates          8.E-01       W or D; dependent
 P                                                         upon associated
                                                           element

Platinum/        78      All forms           1.E-02       D
 Pt

Plutonium/       94      Oxides, hydroxides  1.E-05       Y
 Pu                      Nitrates                         W
                         All others          1.E-04       W
                         [Note:  Use same    1.E-03
                           values for
                           ingestion]

Polonium/        84      Oxides, hydroxides, 1.E-01       W
 Po                       nitrates
                         All others          1.E-01       D

Potassium/       19      All forms           1.E+00       D
 K

Praesodymium/    59      Oxides, hydroxides, 3.E-04       Y
 Pr                       carbides, fluorides
                         All others          3.E-04       W

Promethlum/      61      Oxides, hydroxides, 3.E-04       Y
 Pm                       carbides, fluorides
                         All others          3.E-04       W

Protactinium/    91      Oxides, hydroxides  1.E-03
 Pa                      All others          1.E-03       W

Radium/          88      All forms           2.E-01       W
 Ra

                         Figure III-2 (contd)

Element/       Atomic                                         Lung
Symbol         Number        Compound          f 1/       Retention Class
-------------- --------- ------------------- ------------ -----------------
Rhenium/         75      Oxides, hydroxides, 8.E-01       W
 Re                       halides, nitrates
                         All others          8.E-01       D

Rhodium/         45      Oxides, hydroxides  5.E-02       Y
 Rh                      Halides             5.E-02       W
                         All others          5.E-02       D

Rubidium/        37      All forms           1.E+00       D
 Rb

Ruthenium/       44      Oxides, hydroxides  5.E-02       Y
 Ru                      Halides             5.E-02       W
                         All others          5.E-02       D

Samarium/        62      All forms           3.E-04       W
 Sm

Scandium/        21      All forms           1.E-04       Y
 Sc

Selenium/        34      Oxides, hydroxides, 8.E-01       W
 Se                       carbides
                         All others          8.E-01       D
                         Ingestion only      5.E-02

Silicon/         14      Ceramic forms       1.E-02       Y
 Si                      Oxides, hydroxides, 1.E-02       W
                          carbides, nitrates
                         All others          1.E-02       D

Silver/          47      Oxides, hydroxides  5.E-02       Y
 Ag                      Nitrates, sulphides 5.E-02       W
                         All others,         5.E-02       D
                          elemental form

Sodium/          11      All Forms           1.E+00       D
 Na

Strontium/       38      SrTiO3              1.E-02       Y
 Sr                      All others          3.E-01       D
                          (soluble)

                         Figure III-2 (contd)

Element/       Atomic                                         Lung
Symbol         Number        Compound          f 1/       Retention Class
-------------- --------- ------------------- ------------ -----------------
Sulfur/          16      Sulphates,          1.E-01       W or D; dependent
 S                        sulphides                        upon associated
                                                           element
                         All inorganic       8.E-01
                         Elemental form      1.E-01       W
                         Gases               1.E+00       D

Tantalum/        73      Oxides, hydroxides, 1.E-03       Y
 Ta                       halides, carbides,
                          nitrates, nitrides
                         All others          1.E-03       W

Technetium/      43      Oxides, hydroxides, 8.E-01       W
 Tc                       halides, nitrates
                         All others          8.E-01       D

Tellurium/       52      Oxides, hydroxides, 2.E-01       W
 Te                       nitrates
                         All others          2.E-01       D

Terbium/         65      All forms           3.E-04       W
 Tb

Thallium/        81      All forms           1.E+00       D
 Tl

Thorium/         90      Oxides, hydroxides  2.E-04       Y
 Th                      All others          2.E-04       W

Thulium/         69      All forms           3.E-04       W
 Tm

Tin/             50      Oxides, hydroxides, 2.E-02       W
 Sn                       halides, nitrates,
                          sulphides,
                          Sn3(PO4)4
                         All others          2.E-02       D

Titanium/        22      SrTiO3              1.E-02       Y
 Ti                      Oxides, hydroxides, 1.E-02       W
                          carbides, halides,
                          nitrates
                         All others          1.E-02       D

                         Figure III-2 (contd)

Element/       Atomic                                         Lung
Symbol         Number        Compound          f 1/       Retention Class
-------------- --------- ------------------- ------------ ---------------
Tungsten/        74      Ingestion 2/
 W                       Tungstic acid       1.E-02
                         All others          3.E-01

Uranium/         92      UO2, U3O8           2.E-03       Y
 U                       UO3, tetravalent    5.E-02       W
                          compounds
                         UF6, uranyl         5.E-02       D
                          compounds

Vanadium/        23      Oxides, hydroxides, 1.E-02       W
 V                        carbides, halides
                         All others          1.E-02       D

Ytterbium/       70      Oxides, hydroxides, 3.E-04       Y
 Yb                       fluorides
                         All others          3.E-04       W

Yttrium/         39      Oxides, hydroxides  1.E-04       Y
 Y                       All others          1.E-04       W

Zinc/            30      All forms           5.E-01       Y
 Zn

Zirconium/       40      Carbides            2.E-03       Y
 Zr                      Oxides, hydroxides, 2.E-03       W
                          halides, nitrates
                         All others          2.E-03       D
----------------

1/  A dash indicates no data For the value shown.
2/  For ingestion, no lung retention classes are listed.

                         Figure III-2 (contd)

                                               Air Immersion
   Radionuclide               Half-Life        DCG (microCi/mL)
   ------------               ---------        ----------------
     C-11                     20.48 min           2.E-08

     N-13                     9.97 min            2.E-08
     N-16                     7.13 s              3.E-09

     O-15                     122.24 s            2.E-08

     F-18 1/                  109.74 min          2.E-08

     Na-24 1/                 15.00 h             4.E-09

     Mg-27 2/                 9.458 min           2.E-08

     Al-28 2/                 2.240 min           1.E-08

     Cl-38 1/                 37.21 min           1.E-08

     Ar-37                    35.02 d             1.E-02
     Ar-39                    269 yr              4.E-06 3/
     Ar-41                    1.827 h             1.E-08

     K-43 1/                  22.6 h              2.E-08

     Ca-49 2/                 8.719 min           5.E-09

     Sc-44 1/                 3.927 h             9.E-09
     Sc-46m 2/                18.72 s             2.E-07

     Ti-45 1/                 3.08 h              2.E-08
     Ti-51 2/                 5.752 min           5.E-08

     V-52 2/                  3.75 min            1.E-08

     Cr-49 1/                 42.09 min           2.E-08

     Mn-52m 1/                21.4 min            8.E-09
     Mn-56 1/                 2.5785 h            1.E-08
     Mn-57 2/                 1.47 min            2.E-07

     Co-60m 1/                10.47 min           4.E-06

     Ni-57 1/,/4              36.08 h             1.E-08

                             Figure III-3
    Derived Concentration Guides (DCGs) For Members of the Public from
  External Exposure During Immersion in a Contaminated Atmospheric Cloud

                                               Air Immersion
   Radionuclide               Half-Life        DCG (microCi/mL)
   ------------               ---------        ----------------
     Ni-65 1/, 5/             2.520 h             3.E-08

     Cu-61 1/                 3.408 h             2.E-08
     Cu-62 2/                 9.74 min            2.E-08

     Ga-66 1/                 9.40 h              7.E-09
     Ga-68 1/                 68.0 min            2.E-08
     Ga-72 1/                 14.1 h              7.E-09

     Se-73 1/                 7.15 h              2.E-08

     Br-77 1/                 57.04 h             6.E-08 6/
     Br-80 1/                 17.4 min            2.E-07
     Br-82 1/                 35.30 h             7.E-09
     Br-84 1/                 31.80 min           1.E-08
     Br-85 2/                 172 s               2.E-07

     Kr-79                    35.04 h             8.E-08
     Kr-81                    2.1E+05 yr          2.E-06
     Kr-83m                   1.83 h              2.E-04
     Kr-85                    10.72 yr            3.E-O6 3/
     Kr-85m                   4.48 h              1.E-07
     Kr-87                    76.3 min            2.E-08
     Kr-88                    2.84 h              9.E-09
     Kr-89                    3.16 min            1.E-08
     Kr-90                    32.32 s             1.E-08

     Rb-81 1/                 4.58 h              3.E-08
     Rb-82 2/                 1.25 min            2.E-08
     Rb-88 1/                 17.8 min            3.E-08
     Rb-89 1/                 15.44 min           9.E-09
     Rb-90 2/                 157 s               8.E-09
     Rb-90m 2/                258 s               5.E-09

     Sr-85m 1/                67.66 min           9.E-08
     Sr-87m 1/                2.805 h             6.E-08
     Sr-92 1/                 2.71 h              1.E-08
     Sr-93 2/                 7.3 min             8.E-09

     Y-86 1/                  14.74 h             5.E-09
     Y-90m 1/                 3.19 h              3.E-08 6/
     Y-91m 1/                 49.71 min           4.E-08

     Nb-90 1/                 14.60 h             4.E-09

                           Figure III-3 (contd)

                                               Air Immersion
   Radionuclide               Half-Life        DCG (microCi/mL)
   ------------               ---------        ----------------
     Nb-94m 2/                6.26 min            4.E-06
     Nb-97 1/                 72.1 min            3.E-08
     Nb-97m 1/                60 s                3.E-08

     Mo-91 2/                 15.49 min           2.E-08
     Mo-101 1/                14.61 min           1.E-08

     Tc-95 1/                 20.0 h              2.E-08
     Tc-96m 1/                51.5 min            5.E-07
     Tc-99m 1/                6.02 h              1.E-07
     Tc-101 1/                14.2 min            6.E-08

     Ru-105 1/                4.44 h              2.E-08

     Rh-105m 2/               45 s                7.E-07
     Rh-106 2/                29.92 s             8.E-08

     Ag-108 2/                2.37 min            7.E-07
     Ag-109m 2/               39.6 s              4.E-06
     Ag-110 2/                24.57 s             4.E-07

     Cd-111m 2/               48.7 min            7.E-08
     Cd-117 1/                2.49 h              2.E-08
     Cd-117m 1/               3.36 h              9.E-09

     In-113m 1/               1.658 h             8.E-08
     In-114 2/                71.9 s              5.E-07
     In-116m 1/               54.15 min           8.E-09
     In-117 1/                43.8 min            3.E-08

     Sb-117 1/                2.80 h              1.E-07
     Sb-126m 1/               19.0 min            1.E-08
     Sb-129 1/                4.40 h              1.E-08

     Te-133 1/                12.45 min           2.E-08
     Te-133m 1/               55.4 min            8.E-09
     Te-134 1/                41.8 min            2.E-08

     I-122 2/                 3.62 min            2.E-08
     I-128 1/                 24.99 min           2.E-07
     I-132 1/                 2.30 h              8.E-09
     I-134 1/                 52.6 min            7.E-09
     I-I35 1/                 6.61 h              1.E-08 6/
     I-136 2/                 83 s                7.E-09

                           Figure III-3 (contd)

                                               Air Immersion
   Radionuclide               Half-Life        DCG (microCi/mL)
   ------------               ---------        ----------------
     Xe-122                   20.1 h              3.E-07
     Xe-123                   2.14 h              3.E-08
     Xe-125                   16.8 h              8.E-08
     Xe-127                   36.406 d            7.E-08
     Xe-129m                  8.89 d              8.E-07
     Xe-131m                  11.84 d             2.E-06
     Xe-133                   5.245 d             5.E-07
     Xe-133m                  2.19 d              6.E-07
     Xe-135                   9.11 h              8.E-08
     Xe-135m                  15.36 min           5.E-08
     Xe-137                   3.83 min            9.E-08
     Xe-138                   14.13 min           2.E-08
     Cs-126 2/                1.64 min            2.E-08
     Cs-129 1/                32.06 h             8.E-08 6/
     Cs-138 1/                32.2 min            8.E-09
     Cs-139 2/                9.40 min            5.E-08

     Ba-137m 2/               2.552 min           3.E-08
     Ba-141 1/                18.27 min           2.E-08
     Ba-142 1/                10.70 min           2.E-08

     La-142 1/                95.4 min            6.E-09

     Pr-144m 2/               7.2 min             4.E-06

     Nd-149 1/                1.73 h              5.E-08

     Gd-162 2/                9.7 min             5.E-08

     Td-162 2/                7.76 min            2.E-08

     Dy-157 1/                8.06 h              6.E-08

     Re-182m 1/               12.7 h              2.E-08

     Os-190m 1/               9.9 min             1.E-08

     Ir-190m 1/               3.2 h               5.E-07 6/

     Au-195m 2/               30.6 s              1.E-07

                           Figure III-3 (contd)

                                               Air Immersion
   Radionuclide               Half-Life        DCG (microCi/mL)
   ------------               ---------        ----------------
     Tl-200 1/                26.1 h              1.E-08
     Tl-207 2/                4.77 min            1.E-06 3/
     Tl-208 2/                3.053 min           5.E-09
     Tl-209 2/                2.20 min            9.E-09
     Tl-210 2/                1.30 min            7.E-09

     Pb-204m 2/               66.9 min            9.E-09

     Bi-211 2/                2.13 min            4.E-07

     Po-211 2/                0.516 s             2.E-06

     Rn-220 7/                55.61 s             3.E-09
     Rn-222 7/                3.82 d              3.E-09

     Th-233 2/                22.3 min            5.E-07

     Pa-234 1/                6.70 h              1.E-08
     Pa-234m 2/               1.17 min            8.E-07 3/

     U-239 1/                 23.40 min           4.E-07 6/

     Np-240 1/                65 min              2.E-08
     Np-240m 2/               7.4 min             6.E-08

     Am-246 1/                25.0 min            2.E-08

----------------------

1/  Committed effective dose equivalent from inhalation is calculated in
    ICRP Publication 30, but the DCG value for external exposure to a
    contaminated atmospheric cloud is more restrictive than the DCG value
    for inhalation.

2/  Committed effective dose equivalent from inhalation is not calculated in
    ICRP Publication 30, but DCG value for external exposure to contaminated
    cloud should be more restrictive than DCG value for inhalation due to
    relatively short half-life of radionuclide.

3/  DCG value is determined by limit on annual dose equivalent to skin,
    rather than limit on annual effective dose equivalent.

4/  DCG value applies to radionuclide in vapor form only; DCG value for
    inhalation is more restrictive for radionuclide in inorganic form.

5/  DCG value applies to radionuclide in inorganic or vapor form.

6/  DCG value for exposure to contaminated atmospheric cloud is the same as
    DCG value for inhalation.

7/  The value shown for radon gas is a result of unit conversion from 3
    pCi/L to 3 microCi/mL.

                           Figure III-3 (contd)



                              CHAPTER IV

                      RESIDUAL RADIOACTIVE MATERIAL

1.  PURPOSE.  This chapter presents radiological protection requirements
    and guidelines for cleanup of residual radioactive material and
    management of the resulting wastes and residues and release of property.
    These requirements and guidelines are applicable at the time the
    property is released.  Property subject to these criteria includes, but
    is not limited to sites identified by the Formerly Utilized Sites
    Remedial Action Program (FUSRAP) and the Surplus Facilities Management
    Program (SFMP).  The topics covered are basic dose limits, guidelines
    and authorized limits for allowable levels of residual radioactive
    material, and control of the radioactive wastes and residues.  This
    chapter does not apply to uranium mill tailings or to properties covered
    by mandatory legal requirements.

2.  IMPLEMENTATION.  DOE elements shall develop plans and protocols for the
    implementation of this guidance.  FUSRAP sites shall be identified,
    characterized, and designated, as such, for remedial action and
    certified for release.  Information on applications of the guidelines
    and requirements presented herein, including procedures for deriving
    specific property guidelines for allowable levels of residual
    radioactive material from basic dose limits, is contained in DOE/CH
    8901, "A Manual for Implementing Residual Radioactive Material
    Guidelines, A Supplement to the U.S. Department of Energy Guidelines
    for Residual Radioactive Material at FUSRAP and SFMP Sites," June 1989.

    a.  Residual Radioactive Material.  This chapter provides guidance on
        radiation protection of the public and the environment from:

        (1)  Residual concentrations of radionuclides in soil (for these
             purposes, soil is defined as unconsolidated earth material,
             including rubble and debris that might be present in earth
             material);

        (2)  Concentrations of airborne radon decay products;

        (3)  External gamma radiation;

        (4)  Surface contamination; and

        (5)  Radionuclide concentrations in air or water resulting from or
             associated with any of the above.

    b.  Basic Dose Limit.  The basic dose limit for doses resulting from
        exposures to residual radioactive material is a prescribed standard
        from which limits for quantities that can be monitored and
        controlled are derived; it is specified in terms of the effective
        dose equivalent as defined in this Order.  The basic dose limits are
        used for deriving guidelines for residual concentrations of
        radionuclides in soil.  Guidelines for residual concentrations of
        thorium and radium in soil, concentrations of airborne radon decay
        products, allowable indoor external gamma radiation levels, and
        residual surface contamination concentrations are based on existing
        radiological protection standards (40 CFR Part 192; NRC Regulatory
        Guide 1.86 and subsequent NRC guidance on residual radioactive
        material).  Derived guidelines or limits based on the basic dose
        limits for those quantities are used only when the guidelines
        provided in the existing standards are shown to be inappropriate.

    c.  Guideline.  A guideline for residual radioactive material is a level
        of radioactive material that is acceptable for use of property
        without restrictions due to residual radioactive material.
        Guidelines for residual radioactive material presented herein are of
        two kinds, generic and specific.  The basis for the guidelines is
        generally a presumed worst-case plausible-use scenario for the
        property.

        (1)  Generic guidelines, independent of the property, are taken
             from existing radiation protection standards.  Generic
             guideline values are presented in this chapter.

        (2)  Specific property guidelines are derived from basic dose
             limits using specific property models and data.  Procedures
             and data for deriving specific property guideline values are
             given by DOE/CH-8901.

    d.  Authorized Limit.  An authorized limit is a level of residual
        radioactive material that shall not be exceeded if the remedial
        action is to be considered completed and the property is to be
        released without restrictions on use due to residual radioactive
        material.

        (1)  The authorized limits for a property will include:

             (a)  Limits for each radionuclide or group of radionuclides,
                  as appropriate, associated with residual radioactive
                  material in soil or in surface contamination of structures
                  and equipment;

             (b)  Limits for each radionuclide or group of radionuclides,
                  as appropriate, in air or water; and

             (c)  Where appropriate, a limit on external gamma radiation
                  resulting from the residual material.

        (2)  Under normal circumstances expected at most properties,
             authorized limits for residual radioactive material are set
             equal to, or below, guideline values.  Exceptional conditions
             for which authorized limits might differ from guideline
             values are specified in paragraphs IV-5 and IV-7.

        (3)  A property may be released without restrictions if residual
             radioactive material does not exceed the authorized limits or
             approved supplemental limits, as defined in paragraph IV.7a,
             at the time remedial action is completed.  DOE actions in
             regard to restrictions and controls on use of the property
             shall be governed by provisions in paragraph IV.7b.  The
             applicable controls and restrictions are specified in
             paragraph IV.6 and IV.7.c.

    e.  ALARA Applications.  The monitoring, cleanup, and control of
        residual radioactive material are subject to the ALARA policy of
        this Order.  Applications of ALARA policy shall be documented and
        filed as a permanent record.

3.  BASIC DOSE LIMITS.

    a.  Defining and Determining Dose Limits.  The basic public dose limits
        for exposure to residual radioactive material, in addition to
        natural occurring "background" exposures, are 100 mrem (1 mSv)
        effective dose equivalent in a year, as specified in paragraph
        II.1a.

    b.  Unusual Circumstances.  If, under unusual circumstances, it is
        impracticable to meet the basic limit based on realistic exposure
        scenarios, the respective project and/or program office may,
        pursuant to paragraph II.1a(4), request from EH-1 for a specific
        authorization for a temporary dose limit higher than 100 mrem (1
        mSv), but not greater than 500 mrem (5 mSv), in a year.  Such
        unusual circumstances may include temporary conditions at a
        property scheduled for remedial action or following the remedial
        action.  The ALARA process shall apply to the selection of
        temporary dose limits.

4.  GUIDELINES FOR RESIDUAL RADIOACTIVE MATERIAL.

    a.  Residual Radionuclides in Soil.  Generic guidelines for thorium
        and radium are specified below.  Guidelines for residual
        concentrations of other radionuclides shall be derived from the
        basic dose limits by means of an environmental pathway analysis
        using specific property data where available.  Procedures for
        these derivations are given in DOE/CH-8901.  Residual concentrations
        of radioactive material in soil are defined as those in excess of
        background concentrations averaged over an area of 100 m2.

        (1)  Hot Spots.  If the average concentration in any surface or
             below-surface area less than or equal to 25 m2, exceeds the
             limit or guideline by a factor of (100/A)0.5, [where A is the
             area (in square meters) of the region in which concentrations
             are elevated], limits for "hot-spots" shall also be developed
             and applied.  Procedures for calculating these hot-spot
             limits, which depend on the extent of the elevated local
             concentrations, are given in DOE/CH-8901.  In addition,
             reasonable efforts shall be made to remove any source of
             radionuclide that exceeds 30 times the appropriate limit for
             soil, irrespective of the average concentration in the soil.

        (2)  Generic Guidelines.  The generic guidelines for residual
             concentrations of Ra-226, Ra-228, Th-230, and Th-232 are:

             (a)  5 pCi/g, averaged over the first 15 cm of soil below the
                  surface; and

             (b)  15 pCi/g, averaged over 15-cm-thick layers of soil more
                  than 15 cm below the surface.

        (3)  Ingrowth and Mixtures.  These guidelines take into account
             ingrowth of Ra-226 from Th-230 and of Ra-228 from Th-232, and
             assume secular equilibrium.  If both Th-230 and Ra-226 or
             both Th-232 and Ra-228 are present and not in secular
             equilibrium, the appropriate guideline is applied as a limit
             for the radionuclide with the higher concentration.  If other
             mixtures of radionuclides occur, the concentrations of
             individual radionuclides shall be reduced so that either the
             dose for the mixtures will not exceed the basic dose limit or
             the sum of the ratios of the soil concentration of each
             radionuclide to the allowable limit for that radionuclide
             will not exceed 1.  Explicit formulas for calculating
             residual concentration guidelines for mixtures are given in
             DOE/CH-8901.

    b.  Airborne Radon Decay Products.  Generic guidelines for
        concentrations of airborne radon decay products shall apply to
        existing occupied or habitable structures on private property that
        are intended for release without restriction; structures that will
        be demolished or buried are excluded.  The applicable generic
        guideline (40 CFR Part 192) is:  In any occupied or habitable
        building, the objective of remedial action shall be, and a
        reasonable effort shall be made to achieve, an annual average (or
        equivalent) radon decay product concentration (including background)
        not to exceed 0.02 WL.  [A working level (WL) is any combination of
        short-lived radon decay products in 1 L of air that will result in
        the ultimate emission of 1.3 x 10 5 MeV of potential alpha energy.]
        In any case, the radon decay product concentration (including
        background) shall not exceed 0.03 WL.  Remedial actions by DOE are
        not required in order to comply with this guideline when there is
        reasonable assurance that residual radioactive material is not the
        source of the radon concentration.

    c.  External Gamma Radiation.  The average level of gamma radiation
        inside a building or habitable structure on a site to be released
        without restrictions shall not exceed the background level by more
        than 20 micro R/h and shall comply with the basic dose limit when
        an "appropriate-use" scenario is considered.  This requirement
        shall not necessarily apply to structures scheduled for demolition
        or to buried foundations.  External gamma radiation levels on open
        lands shall also comply with the basic limit and the ALARA process,
        considering appropriate-use scenarios for the area.

    d.  Surface Contamination.  The generic surface contamination guidelines
        provided in Figure IV-1 are applicable to existing structures and
        equipment.  These guidelines are generally consistent with standards
        of the NRC (NRC 1982) and functionally equivalent to Section 4,
        "Decontamination for Release for Unrestricted Use," of Regulatory
        Guide 1.86, but apply to nonreactor facilities.  These limits apply
        to both interior equipment and building components that are
        potentially salvageable or recoverable scrap.  If a building is
        demolished, the guidelines in paragraph IV.6a are applicable to the
        resulting contamination in the ground.

    e.  Residual Radionuclides in Air and Water.  Residual concentrations
        of radionuclides in air and water shall be controlled to the
        required levels shown in paragraph II.1a and as required by other
        applicable Federal and/or State laws.

5.  AUTHORIZED LIMITS FOR RESIDUAL RADIOACTIVE MATERIAL.

    a.  Establishment of Authorized Limits.  The authorized limits for each
        property shall be set equal to the generic or derived guidelines
        unless it can be established, on the basis of specific property data
        (including health, safety, practical, programmatic and socioeconomic
        considerations), that the guidelines are not appropriate for use at
        the specific property.  The authorized limits shall be established
        to (1) provide that, at a minimum, the basic dose limits of in
        paragraph IV.3, will not be exceeded under the "worst-case" or
        "plausible-use" scenarios, consistent with the procedures and
        guidance provided in DOE/CH-8901, or (2) be consistent with
        applicable generic guidelines.  The authorized limits shall be
        consistent with limits and guidelines established by other
        applicable Federal and State laws.  The authorized limits are
        developed through the project offices in the field and are approved
        by the Headquarters Program Office.

----------------------------------------------------------------------------
                            Allowable Total Residual Surface Contamination
                                             (dpm/100 cm2) 1/
Radionuclides 2/              Average 3/,4/  Maximum 4/,5/  Removable 4/,6/
-------------                 -------        -------        ---------

Transuranics, I-125, I-129,   RESERVED       RESERVED       RESERVED
Ra-226, Ac-227, Ra-228,
Th-228, Th-230, Pa-231.

Th-Natural, Sr-90, I-126,       1,000          3,000            200
I-131, I-133, Ra-223,
Ra-224, U-232, Th-232.

U-Natural, U-235, U-238,        5,000         15,000          1,000
and associated decay
product, alpha emitters.

Beta-gamma emitters             5,000         15,000          1,000
(radionuclides with decay
modes other than alpha
emission or spontaneous
fission) except Sr-90 and
others noted above. 7/

---------------------------
1/  As used in this table, dpm (disintegrations per minute) means the rate
    of emission by radioactive material as determined by correcting the
    counts per minute measured by an appropriate detector for background,
    efficiency, and geometric factors associated with the instrumentation.

2/  Where surface contamination by both alpha- and beta-gamma-emitting
    radionuclides exists, the limits established for alpha- and
    beta-gamma-emitting radionuclides should apply independently.

3/  Measurements of average contamination should not be averaged over an
    area of more than 1 m2.  For objects of less surface area, the average
    should be derived for each such object.

4/  The average and maximum dose rates associated with surface contamination
    resulting from beta-gamma emitters should not exceed 0.2 mrad/h and 1.0
    mrad/h, respectively, at 1 cm.

5/  The maximum contamination level applies to an area of not more than 100
    cm2.

6/  The amount of removable material per 100 cm2 of surface area should be
    determined by wiping an area of that size with dry filter or soft
    absorbent paper, applying moderate pressure, and measuring the amount
    of radioactive material on the wiping with an appropriate instrument of
    known efficiency.  When removable contamination on objects of surface
    area less than 100 cm2 is determined, the activity per unit area should
    be based on the actual area and the entire surface should be wiped.  It
    is not necessary to use wiping techniques to measure removable
    contamination levels if direct scan surveys indicate that the total
    residual surface contamination levels are within the limits for
    removable contamination.

7/  This category of radionuclides includes mixed fission products,
    including the Sr-90 which is present in them.  It does not apply to
    Sr-90 which has been separated from the other fission products or
    mixtures where the Sr-90 has been enriched.
----------------------------------------------------------------------------
                                Figure IV-1
                     Surface Contamination Guidelines


    b.  Application of Authorized Limits.  Remedial action shall not be
        considered complete until the residual radioactive material levels
        comply with the authorized limits, except as authorized pursuant
        to paragraph IV.7 for special situations where the supplemental
        limits and exceptions should be considered and it is demonstrated
        that it is not appropriate to decontaminate the area to the
        authorized limit or guideline value.

6.  CONTROL OF RESIDUAL RADIOACTIVE MATERIAL.  Residual radioactive
    material above the guidelines shall be managed in accordance with
    Chapter II and the following requirements.

    a.  Operational and Control Requirements.  The operational and control
        requirements specified in the following Orders shall apply to
        interim storage, interim management, and long-term management.

        (1)  DOE 5000.3B, Occurrence Reporting and Processing of Operations
             Information

        (2)  DOE 5440.1E, National Environmental Policy Act Compliance
             Program

        (3)  DOE 5480.4, Environmental Protection, Safety, and Health
             Protection Standards

        (4)  DOE 5482.1B, Environmental, Safety, and Health Appraisal
             Program

        (5)  DOE 5483.1A, Occupational Safety and Health Program for DOE
             Employees at Government-Owned, Contractor-Operated Facilities

        (6)  DOE 5484.1, Environmental Protection, Safety, and Health
             Protection Information Reporting Requirements

        (7)  DOE 5820.2A, Radioactive Waste Management.

    b.  Interim Storage.

        (1)  Control and stabilization features shall be designed to
             provide, to the extent reasonably achievable, an effective
             life of 50 years with a minimum life of at least 25 years.

        (2)  Controls shall be designed such that Rn-222 concentrations in
             the atmosphere above facility surfaces or openings in
             addition to background levels, will not exceed:

             (a)  100 pCi/L at any given point;

             (b)  An annual average concentration of 30 pCi/L over the
                  facility site; and

             (c)  An annual average concentration of 3 pCi/L at or above
                  any location outside the facility site.

             (d)  Flux rates from the storage of radon producing wastes
                  shall not exceed 20 pCi/sq.m-sec., as required by 40 CFR
                  Part 61.

        (3)  Controls shall be designed such that concentrations of
             radionuclides in the groundwater and quantities of residual
             radioactive material will not exceed applicable Federal or
             State standards.

        (4)  Access to a property and use of onsite material contaminated
             by residual radioactive material should be controlled through
             appropriate administrative and physical controls such as
             those described in 40 CFR Part 192.  These control features
             should be designed to provide, to the extent reasonable, an
             effective life of at least 25 years.

    c.  Interim Management.

        (1)  A property may be maintained under an interim management
             arrangement when the residual radioactive material exceeds
             guideline values if the residual radioactive material is in
             inaccessible locations and would be unreasonably costly to
             remove provided that administrative controls are established
             by the responsible authority (Federal, State, or local) to
             protect members of the public and that such controls are
             approved by the appropriate Program Secretarial Officer.

        (2)  The administrative controls include but are not limited to
             periodic monitoring as appropriate; appropriate shielding;
             physical barriers to prevent access; and appropriate
             radiological safety measures during maintenance, renovation,
             demolition, or other activities that might disturb the
             residual radioactive material or cause it to migrate.

        (3)  The owner of the property should be responsible for
             implementing the administrative controls and the cognizant
             Federal, State, or local authorities should be responsible
             for enforcing them.

    d.  Long-Term Management.

        (1)  Uranium, Thorium, and Their Decay Products.

             (a)  Control and stabilization features shall be designed to
                  provide, to the extent reasonably achievable, an effective
                  life of 1,000 years with a minimum life of at least 200
                  years.

             (b)  Control and stabilization features shall be designed to
                  limit Rn-222 emanation to the atmosphere from the wastes
                  to less than an annual average release rate of 20
                  pCi/m2/s and prevent increases in the annual average
                  Rn-222 concentration at or above any location outside
                  the boundary of the contaminated area by more than 0.5
                  pCi/L.  Field verification of emanation rates shall be
                  in accordance with the requirements of 40 CFR Part 61.

             (c)  Before any potentially biodegradable contaminated wastes
                  are placed in a long-term management facility, such
                  wastes shall be properly conditioned so that the
                  generation and escape of biogenic gases will not cause
                  the requirement in paragraph IV.6d(1)(b) to be exceeded
                  and that biodegradation within the facility will not
                  result in premature structural failure in violation of
                  the requirements in paragraph IV.6d(1)(a).

             (d)  Ground water shall be protected in accordance with
                  legally applicable Federal and State standards.

             (e)  Access to a property and use of onsite material
                  contaminated by residual radioactive material should be
                  controlled through appropriate administrative and
                  physical controls such as those described in 40 CFR Part
                  192.  These controls should be designed to be effective
                  to the extent reasonable for at least 200 years.

        (2)  Other Radionuclides.  Long-term management of other
             radionuclides shall be in accordance with Chapters II, III,
             and IV of DOE 5820.2A, as applicable.

7.  SUPPLEMENTAL LIMITS AND EXCEPTIONS.  If special specific property
    circumstances indicate that the guidelines or authorized limits
    established for a given property are not appropriate for any portion of
    that property, then the DOE Field Office Manager may request, through
    the Program Office, that supplemental limits or an exception be applied.
    The responsible DOE Field Office Manager shall document the decision
    that the subject guidelines or authorized limits are not appropriate and
    that the alternative action selected will provide adequate protection,
    giving due consideration to health and safety, the environment, costs,
    and public policy considerations.  The DOE Field Office Manager shall
    obtain approval for specific supplemental limits or exceptions from
    Headquarters as specified in paragraph IV.5, and shall provide to the
    Headquarters Program Office those materials required by Headquarters for
    the justification as specified in this paragraph and in the FUSRAP and
    SFMP protocols and subsequent guidance documents.  The DOE Field Office
    Manager shall also be responsible for coordination with the State and
    local government regarding the limits or exceptions and associated
    restrictions as appropriate.  In the case of exceptions, the DOE Field
    Office Manager shall be responsible for coordinating with the State
    and/or local governments to ensure the adequacy of restrictions or
    conditions of release and that mechanisms are in place for their
    enforcement.

    a.  Supplemental Limits.  Any supplemental limits shall achieve the
        basic dose limits set forth in Chapter II of this Order for both
        current and potential unrestricted uses of a property.  Supplemental
        limits may be applied to any portion of a property if, on the basis
        of a specific property analysis, it is demonstrated that

        (1)  Certain aspects of the property were not considered in the
             development of the established authorized limits for that
             property; and

        (2)  As a result of these certain aspects, the established limits
             either do not provide adequate protection or are unnecessarily
             restrictive and costly.

    b.  Exceptions to the authorized limits defined for a property may be
        applied to any portion of the property when it is established that
        the authorized limits cannot reasonably be achieved and that
        restrictions on use of the property are necessary.  It shall be
        demonstrated that the exception is justified and that the
        restrictions will protect members of the public within the basic
        dose limits of this Order and will comply with the requirements
        for control of residual radioactive material as set forth in
        paragraph IV.6.

    c.  Justification for Supplemental Limits and Exceptions.  The need for
        supplemental limits and exceptions shall be documented by the DOE
        Field Office on a case-by-case basis using specific property data.
        Every reasonable effort should be made to minimize the use of
        supplemental limits and exceptions.  Examples of specific situations
        that warrant DOE use of supplemental standards and exceptions are:

        (1)  Where remedial action would pose a clear and present risk of
             injury to workers or members of the public, notwithstanding
             reasonable measures to avoid or reduce risk.

        (2)  Where remedial action, even after all reasonable mitigative
             measures have been taken, would produce environmental harm
             that is clearly excessive compared to the health benefits to
             persons living on or near affected properties, now or in the
             future.  A clear excess of environmental harm is harm that is
             long-term, manifest, and grossly disproportionate to health
             benefits that may reasonably be anticipated.

        (3)  Where it is determined that the scenarios or assumptions used
             to establish the authorized limits do not apply to the property
             or portion of the property identified, or where more
             appropriate scenarios or assumptions indicate that other limits
             are applicable or appropriate for protection of the public and
             the environment.

        (4)  Where the cost of remedial action for contaminated soil is
             unreasonably high relative to long-term benefits and where
             the residual material does not pose a clear present or future
             risk after taking necessary control measure.  The likelihood
             that buildings will be erected or that people will spend long
             periods of time at such a property should be considered in
             evaluating this risk.  Remedial action will generally not be
             necessary where only minor quantities of residual radioactive
             material are involved or where residual radioactive material
             occurs in an inaccessible location at which specific property
             factors limit its hazard and from which it is difficult or
             costly to remove.  Examples include residual radioactive
             material under hard-surfaced public roads and sidewalks,
             around public sewer lines, or in fence-post foundations.  A
             specific property analysis shall be provided to establish
             that the residual radioactive material would not cause an
             individual to receive a radiation dose in excess of the basic
             dose limits stated in paragraph IV.3, and a statement
             specifying the level of residual radioactive material shall
             be provided to the appropriate State and/or local agencies
             for appropriate action, e.g., for inclusion in local land
             records.

        (5)  Where there is no feasible remedial action.

8.  SOURCES.

    a.  Basic Dose Limits.  Dosimetry model and dose limits are defined in
        Chapter II of this Order.

    b.  Generic Guidelines for Residual Radioactive Material.  Residual
        concentrations of radium and thorium in soil are defined in 40 CFR
        Part 192.  Airborne radon decay products are also defined in 40
        CFR Part 192, as are guidelines for external gamma radiation.  The
        surface contamination definition is adapted from NRC (1982).

    c.  Control of Radioactive Wastes and Residues.  Interim storage is
        guided by this Order and DOE 5820.2A.  Long-term management is
        guided by this Order, 40 CFR Part 192, and DOE 5820.2A.


<>